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ABSTRACT OF THE DISSERTATION 
THE INFLUENCE OF THE PROXIMAL THIOLATE LIGAND AND HYDROGEN 
BOND NETWORK OF THE PROXIMAL HELIX ON THE STRUCTURAL AND 
BIOCHEMICAL PROPERTIES OF CHLOROPEROXIDASE 
by 
Elena Shersher 
Florida International University, 2016 
Miami, Florida 
Professor Xiaotang Wang, Major Professor 
        Chloroperoxidase (CPO) from Caldariomyces fumago is a versatile heme enzyme 
with great potential for environmental and pharmaceutical applications. It catalyzes a 
plethora of reactions including halogenation, dismutation, epoxidation, and oxidation. The 
diverse catalytic capabilities of CPO have long been attributed to the protein’s distinct 
active site that combines structural features of peroxidases and cytochromes P450. 
Particularly, the role of the axial thiolate ligand in CPO catalysis has been much debated. 
Furthermore, no data are available on the role of hydrogen bonding between Arg26 – 
Asn37 and Ala27 – Asn33 of the proximal helix in defining the structural and catalytic 
properties of CPO. 
        In order to investigate the influence of the proximal thiolate and the proximal 
hydrogen bond network on the structural and biochemical properties of CPO, several 
mutant CPOs were constructed and characterized using various spectroscopic techniques 
and enzymatic assays. Cysteine 29, which coordinates to the heme, was replaced with a 
His (C29H) to mimic the proximal ligation of classical peroxidases. The UV-Vis spectrum 
viii 
 
of the carbon monoxide complex of ferrous C29H mutant remained essentially identical to 
that of wild type (WT) CPO and P450 although the ferric state of the variant enzyme 
showed a spectral pattern reminiscent of a classical histidine ligated heme peroxidase. 
Histidine ligation was further confirmed by paramagnetic NMR spectroscopy. Contrary to 
a previous report, the specific chlorination activity of C29H was essentially abolished (less 
than 1% of that of WT CPO) but the epoxidation and peroxidation activities were enhanced 
10-fold and 55-fold, respectively. These findings demonstrate for the first time that the 
heme ligand, Cys29 in CPO, is not a prerequisite for CPO’s unique P450-like spectroscopic 
signatures but is constitutive for the protein’s versatile catalytic activities. 
        Arginine 26 and Asparagine 33 in the proximal heme pocket were replaced with Ala 
(R26A, N33A, and R26A/N33A) to disrupt hydrogen bonding. Tertiary structures and 
heme environments of R26A, N33A, and R26A/N33A differed from those of WT CPO as 
determined by CD spectroscopy. The specific chlorination and dismutation activities of all 
mutants were almost abolished but the peroxidation and epoxidation rates were increased. 
These results show that the proximal hydrogen bond network plays an important role in 
maintaining the structure and catalytic diversity of CPO. 
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CHAPTER I. 
HEME PROTEIN DIVERSITY: STRUCTURE, FUNCTION, APPLICATIONS 
1.1 Introduction to heme proteins 
        Heme proteins are ubiquitous in both eukaryotic and prokaryotic organisms. They 
carry out a variety of biological functions that includes oxygen transport, electron transfer, 
signal transduction (via sensing diatomic gases), and catalysis of various redox reactions 
(Table 1.1).  
Table 1.1. Heme proteins and their biological functions. 
Function Proteins References 
O2 transport or  
storage 
Myoglobin (Mb) 
Hemoglobin 
Leghemoglobin 
Neuroglobin 
Cytoglobin 
(1-3) 
(1-3) 
(4) 
(5-6) 
(7) 
Electron transfer Cytochromes a, b, and c (8-9) 
Signal transduction Guanylate cyclase (NO, CO) 
FixL (O2) 
EcDos (O2, NO, CO) 
NPAS2 (CO) 
HemAT (O2) 
CooA (CO) 
(10-12) 
(13-15) 
(16-17) 
(18-19) 
(20) 
(21-22) 
Catalysis Peroxidases 
Catalases 
NO synthase 
Cytochromes P450 
(23-28) 
(29-30) 
(31) 
(32-33) 
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        Each class of heme proteins contains one or two heme moieties as the prosthetic 
group. In general, the heme consists of a ferrous iron centered inside a substituted 
heterocyclic porphine molecule known as porphyrin. The nature and location of the 
substituents on a porphine determines the type of heme (a, b, c, d1, f, o). The most 
frequently encountered heme groups are shown in Fig. 1.1. The majority of heme proteins 
possess heme b, also known as iron protoporphyrin IX (34). Enzymes containing non-b 
heme groups include cytochromes a, cytochromes c, nitrite reductases, cytochromes b6f, 
and heme-copper oxidases that possess heme a, c, d1, f, and o, respectively (35-39).   
        Since iron protoporphyrin IX is the most common type of heme found in heme 
proteins, the following discussion will concentrate on b-type heme proteins. The iron in 
the heme group is coordinated to the four nitrogens of the porphyrin in addition to one or 
two axial ligands that usually include such amino acids as histidine, cysteine, tyrosine, 
methionine, or lysine (40). In many heme proteins, the heme group is located in proximity 
to an alpha-helix parallel to the porphyrin plane that is responsible for heme-protein 
packing interactions (41). The extent of heme exposure to solvent plays a role in 
determining biochemical properties of the protein (42). In addition, the type of the heme 
group together with the nature of metal ligation and the proximal and distal environment 
in the active site determine the reactivity of heme enzymes and their selectivity toward 
substrates (43-45). 
        The following two sections will describe heme proteins that carry out various catalytic 
functions and utilize either hydrogen peroxide or molecular oxygen to perform a plethora 
of oxidation reactions. I will concentrate my discussion on the family of enzymes called 
peroxidases and, particularly, on fungal chloroperoxidase (CPO) since it is the subject of 
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my research. Structural, spectroscopic, and catalytic properties of CPO will be discussed 
in more detail. 
       
                    Heme a                                                                      Heme b 
                      
                    Heme c                                                                   Heme d1  
Figure 1.1. Structures of heme groups most frequently found in heme proteins. 
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1.2 Peroxidases  
        Classical peroxidases are enzymes capable of catalyzing one-electron oxidations of a 
variety of substrates, using hydrogen peroxide as an oxidizing agent. The majority of 
peroxidases contain a heme group as the co-factor; however, a few are known to utilize 
other co-factors. For example, glutathione peroxidase and phospholipid hydroperoxide 
glutathione peroxidase utilize selenium as a co-factor (46). Originally, peroxidases were 
grouped into two major families: animal and plant peroxidases. However, over time 
peroxidases were found in other organisms including bacteria, and many peroxidases were 
found across different kingdoms of life. Moreover, some peroxidases were found to be able 
to catalyze reactions that are usually performed by other biological catalysts such as 
catalases, oxygenases, and peroxygenases. Therefore, a more appropriate classification of 
peroxidases reflects the types of reactions catalyzed by a particular family. According to 
this classification, heme peroxidases are grouped into 4 superfamilies: peroxidases-
catalases, peroxidases-cyclooxygenases, peroxidases-peroxygenases, and CDE (chlorite-
dismutase-DyP-EfeB) heme peroxidases (47-49). The members of each protein 
superfamily are given in Table 1.2.  
1.2.1 Peroxidase-catalases 
        Peroxidase-catalases, in addition to catalyzing classical peroxidation reactions, are 
able to perform the decomposition of hydrogen peroxide, a reaction typically catalyzed by 
regular catalases to protect cells from oxidative damage (30). Peroxidase-catalases are the 
most diverse and abundant superfamily, and is further divided into subfamilies of Class I, 
Class II, and Class III whose representatives belong to intracellular, fungal extracellular, 
and plant extracellular proteins, respectively. All three classes of peroxidases-catalases 
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contain conserved, catalytically important distal Arg-Trp/Phe-His and proximal His-
Trp/Phe-Asp triads (Fig. 1.2 A-C) (63-66). Proximal heme ligation to a His is similar to 
ligation in other peroxidase families (except peroxygenases) and in contrast to a tyrosine 
proximal heme ligand in monofunctional catalases (67). The proximal His is coordinated 
to the iron of the heme through Nε, and the distal His acts as the acid-base catalyst during 
the formation of Compound I, which is discussed below. 
Table 1.2. Classification of heme peroxidases. 
Superfamily Representative proteins References 
Peroxidase-catalases 
Class I (intracellular) 
 
 
Class II (extracellular fungal) 
 
Class III (extracellular plant) 
(Welinder 1992) 
 
Catalase-peroxidases (KatGs)  
Cytochrome c peroxidase (CcP)  
Ascorbate peroxidase (APO)   
Lignin peroxidase (LiP)  
Manganese peroxidase (MnP)  
Versatile peroxidase (VPO)  
Horseradish peroxidase (HRP)  
 
(50) 
(51) 
(52) 
(24) 
(25) 
(53) 
(23) 
Peroxidase-cyclooxygenases Myeloperoxidase (MPO) 
Eosinophil peroxidase (EPO) 
Lactoperoxidase (LPO) 
Thyroid peroxidase (TPO) 
(26) 
(54) 
(55) 
(56) 
CDE superfamily 
Subfamilies:  
Clds, EfeB, 
DyPs A, B, C, and D 
Chlorite dismutases (Clds) 
Dye-decolorizing peroxidases (DyPs) 
EfeB 
(57-58) 
(59-60) 
(61) 
 
Peroxidase-peroxygenases Chloroperoxidase (CPO) 
Unspecific peroxygenases (UPOs) 
(32-33) 
(62) 
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1.2.2 Peroxidase-cyclooxygenases 
        The members of the peroxidase–cyclooxygenase superfamily catalyze the 
oxygenation of fatty acids in the formation of prostaglandins which are autocrine and 
paracrine lipid mediators involved in pain sensitivity, fever regulation, cell growth control, 
and hormonal regulation (68). The superfamily includes mammalian, plant, fungal, and 
bacterial proteins. Mammalian cyclooxygenases are the most studied and include 
myeloperoxidase, eosinophil peroxidase, lactoperoxidase, and thyroid peroxidase. Active 
sites of mammalian cyclooxygenases possess two ester linkages between the heme group 
and conserved distal aspartate and glutamate residues. Other conserved residues include 
distal His and Asp together with proximal His hydrogen bonded to Asn (Fig. 1.2 D, 69). 
Distal His is involved in the formation of catalytic species, Compound I, while distal 
glutamine residue and several water molecules form a hydrogen-bond network involved in 
halide delivery and binding (47). 
1.2.3 CDE peroxidases 
        The CDE superfamily consists of dye decolorizing peroxidases, chlorite dismutases, 
and EfeB enzymes that are found in fungal, archeal, and bacterial phyla. This superfamily 
of heme enzymes has only been recently identified and only a few members have crystal 
structures available that have been biochemically characterized. The active sites of known 
CDE proteins possess a His-Asp/Glu pair in the proximal pocket and an Asp-Arg pair in 
the distal pocket (49). 
        In contrast to a distal His in other peroxidases, CDE enzymes use aspartic acid in their 
catalysis (70-72). The reactions that are catalyzed by this superfamily include but are not 
limited to: oxidations of azo dyes such as Reactive Black 5, 2,6-dimethoxyphenol, and 
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other substituted phenols, 2,20 -azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS), 
β-carotene, ascorbic acid, and anthraquinone dyes such as Reactive Blue 19, Reactive Blue 
5 (73-79). 
 
 
 
Figure 1.2. Active site structures of cytochrome c peroxidase from Saccharomyces 
cerevisiae (A), lignin peroxidase from Phanerochaete chrysosporium (B), horseradish 
peroxidase from Armoracia rusticana (C), lactoperoxidase from Bubalis bubalis (D), dye 
decolorizing peroxidase from Thanatephorus cucumeris (E), and chloroperoxidase from 
Calderiomyces fumago (F). The following pdb files were used to visualize the active sites: 
1CCA, 1B82, 1ATJ, 2GJM, 3AFV, 1CPO (64-66, 69-71).  
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1.2.4 Peroxidase-peroxygenases 
        Peroxidase-peroxygenases, besides catalyzing peroxidation reaction, are able to 
incorporate oxygen from hydrogen peroxide into various substrates. The most studied 
member of this superfamily is chloroperoxidase from the Caldariomyces fumago fungus, 
which is a focus of my research and will be discussed in detail in section 1.3. Other 
enzymes belonging to this group have only recently been discovered and characterized. 
Examples include unspecific peroxygenases (UPOs) from the basidiomycetous fungi 
Agrocybe aegerita (AaeUPO), Coprinus radians, and Marasmius rotula (80-82). These 
UPOs are functional peroxygenases that transfer an oxygen atom from hydrogen peroxide 
to diverse organic substrates (aromatics, heterocycles, linear and cyclic alkanes/ alkenes, 
fatty acids, etc. (83-86). In addition to these reactions, UPOs are able to catalyze O- and 
N-dealkylation, dechlorination, and halide oxidation (87).  
        A feature that distinguishes this superfamily from other heme peroxidases is the use 
of a Cys residue as the proximal heme ligand instead of a His. Furthermore, active sites of 
known peroxygenases and CPO share common structural motifs R(G/A)PCP(G/A)LN in 
the proximal side and E(N/H)D in the distal side (Fig. 1.3). In addition, the proximal alpha-
helix in both CPO and AaeUPO has a similar orientation, being almost perpendicular to 
the heme plane. The orientation of this alpha-helix has been suggested to fine-tune the 
redox potential of the heme (88).  
        It has been proposed that UPOs are structural hybrids between classical peroxidases 
and cytochrome P450 monooxygenases (CYPs), combining the more polar distal side of 
peroxidases with the proximal thiolate ligation of CYPs (Fig. 1.3) (62). CYPs are heme-
thiolate proteins, whose main function is oxygen insertion into organic substrates using 
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molecular oxygen and NAD(P)H (91). However, some CYPs, such as P450SPα from 
Sphingomonas paucimobilis and P450BSβ from Bacillius subtilis, are capable of using 
hydrogen peroxide or organic peroxide through the ‘peroxide-shunt’ pathway in the 
absence of NAD(P)H (92-93). Peroxygenation reactions carried out by P450s are, however, 
much less efficient than those performed by true peroxygenases. Since peroxygenases 
combine structural features of peroxidases and CYPs, they allow for the utilization of a 
catalytic cycle of classical heme peroxidases with the “peroxide shunt” of P450s in their 
catalysis. Interestingly, spectral studies on CPO and AaeUPO suggest that the latter is 
closer to cytochromes P450 than to CPO and may constitute a functional hybrid of the two 
(94). 
 
 
Figure 1.3. Active site structures of aromatic peroxygenase from A. aegerita (A), 
chloroperoxidase from C. fumago (B), and cytochrome P450 3A4 from Homo sapiens (C). 
The following pdb files were used to visualize the active sites: 2YOR, 1CPO, and 1W0E 
(71, 89, 90). Heme is depicted in purple color and proximal axial ligands are indicated in 
red. Side chains of the proximal amino acids involved in hydrogen bond network (subject 
of chapters 3 and 4) formation are shown in blue. 
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1.3 Chloroperoxidase 
         Chloroperoxidase, produced by the ascomycetous fungus Caldariomyces fumago, is 
a heme-containing protein that belongs to the peroxidase-peroxygenase family. The 
biological function of this extracellular protein is proposed to be the chlorination of 2-
chlorocyclopentane-1,3-dione to 2,2-dichlorocyclopentane-1,3-dione, which is a precursor 
of caldariomycin, a compound with antibacterial properties, thus providing the fungus with 
protection against microbes (95). In addition to halogenation, CPO is able to carry out 
catalysis of a plethora of oxidative reactions that are characteristic of other enzyme classes, 
using hydrogen peroxide as an oxidizing agent. The catalytic diversity of CPO has been 
attributed to its unique structure and will be discussed below. 
1.3.1 The structure of CPO 
        Chloroperoxidase is a heavily glycosylated heme-containing protein with a molecular 
weight of approximately 42 kilodaltons (95). It is initially synthesized as a 373-amino-acid 
precursor polypeptide and then underdoes extensive post-translational modifications that 
include removal of a 21-amino-acid signal peptide from the N-terminus, removal of a 53-
amino-acid sequence from the C-terminus that aids in correct folding, cyclization of N-
terminal glutamic acid into pyroglutamic acid, N- and O-glycosylations, deamidation of 
three amidic residues to their corresponding acids, a disulfide bond formation, and 
incorporation of heme b (71, 96, 97). Interestingly, two isoforms of CPO were identified 
depending on the glycosylation pattern, with the major one possessing 21 sugar groups 
located at 3 N- and 11 O-glycosylation sites (71).  
        Similarly to other heme peroxidases, CPO is folded into N- and C-terminal domains 
with the heme group located between the domains. The secondary structure of CPO 
11 
 
includes 8 alpha helices (A-H) and one small beta pair (Fig. 1.4).  However, the overall 
fold is different from that of classical peroxidases or P450s. In CPO, the proximal heme 
ligand, Cys 29, is located in the N-terminal part of the protein in the N-terminus of the 
helix A (residues 29-38) that is almost perpendicular to the heme plane (71). In CYPs and 
other peroxidases, the proximal ligand is situated in the C-terminal domain of the protein 
in the N-terminus of the helix that is parallel to the heme (98). It has been proposed that 
electropositive environment of helix A at the N-terminus fine-tunes the electronegativity 
of the proximal Cys and influences structural, catalytic, and ligand binding properties of 
CPO (88, 99, 100).  
 
Figure 1.4. Crystal structure of chloroperoxidase from C. fumago. The following PDB file 
was used to visualize CPO: 1CPO (71). Heme is depicted in purple color. Letters indicate 
different helices in CPO structure. 
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        The proximal Cys in CPO is hydrogen-bonded (H-bonded) to the peptide NH groups 
of Ala 31 and Leu 32 situated at the N-terminus of the helix A. Hydrogen bonding between 
Cys and polypeptide amides is a common feature of other thiolate proteins including P450s, 
in which proximal Cys 357 is H-bonded to NH groups of Leu 358, Gly 359, and Gln 360 
(98).  These H-bonds contribute to the increase of the iron redox potential by decreasing 
the negative charge on the Cys ligand, and stabilize the thiolate by preventing its 
protonation and protecting against diatomic reactants, all of which result in the formation 
of inactive forms of the enzyme (101, 102). 
        The active site of CPO shares common structural features with both peroxidases and 
P450 enzymes (Figs. 1.2 and 1.3). In CPO, the heme iron is coordinated to the proximal 
Cys, similarly to P450s and in contrast to the proximal His of traditional peroxidases (71). 
However, the distal pocket of CPO, which is similar to that of classical peroxidases, is 
dramatically different from that of P450s which contains mainly non-polar residues. Some 
distal residues are involved in the formation of Compound I (Cpd I), an active species in 
the catalytic cycle of most heme enzymes. In classical peroxidases, the distal His is 
hydrogen-bonded to an Arg residue and is responsible for the peroxide bond cleavage in 
Cpd I formation. In CPO however, this function is carried out by Glu 183, which is 
hydrogen-bonded to the distal His 105. Arginine and histidine provide a particular 
orientation to the His and Glu, respectively. Therefore, the CPO active site environment is 
somewhat similar to other peroxidases in terms of polarity and spacial arrangement; 
however, it also resembles p450-type enzymes because of the thiolate proximal ligand as 
well as possessing direct accessibility to the heme through a wide channel (Fig. 1.5). 
Access to the heme is typically restricted in classical peroxidases (103). CPO’s wide 
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channel provides access to bulky substrates, such as those involved in oxygen insertion 
reactions, and is likely to be responsible for the observed enantioselectivity of CPO. In 
addition, there is a narrow channel connecting the heme center with the protein surface. 
Bulky and hydrophobic residues make up the narrow channel near the heme center, while 
small and polar residues are located near the exit to the protein surface. The narrow channel 
contains multiple halide binding sites and is proposed to provide halogen ion access to the 
CPO active site. It should be noted that in peroxidases the heme access by substrates is 
restricted; however, the heme edge is accessible by substrates for one-electron oxidations, 
which is in contrast to CPO whose heme edge is inaccessible to most substrates (71, 103). 
It is likely that the unique and unusual structure of CPO facilitates its diverse catalytic 
capabilities.  
 
Figure 1.5. Slice through surface representation of CPO. The two channels are marked by 
arrows, and the heme is shown in magenta. The bromide and iodide binding sites are 
depicted by yellow and blue spheres, respectively (103). 
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1.3.2 Overview of CPO catalytic cycle 
        As previously mentioned, CPO is unique because it is able to catalyze various 
reactions that are usually performed by different groups of enzymes. The catalytic 
pathways are summarized in the diagram created by L. P. Hager (Fig. 1.6). 
        The initial step of CPO catalytic cycle is the conversion of the native ferric enzyme 
(resting state) to the oxo-ferryl cation-radical intermediate ([Fe4+=O]·+) called Compound 
I. In many heme enzymes, Cpd I is efficient in catalyzing only one particular type of 
reaction, depending on the class of the enzyme. In the case of CPO, however, once Cpd I 
is formed, it is able to follow different catalytic pathways. For example, it can either form 
oxo-ferryl Compound II (Cpd II, Fe4+=O, peroxidation pathway), oxo-ferric Compound X 
(Cpd X, Fe3+=O, halogenation pathway), or return to its resting state (Fe3+, dismutation and 
P450 pathways). Such catalytic diversity distinguishes CPO from other biocatalysts and 
attracts the attention of scientists from various fields. 
 
 
Figure 1.6. Catalytic cycle of CPO (created by L. P Hager). 
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1.3.2.1 Active intermediates: Compound I, Compound II, and Compound X. 
        Compound I, an oxo-ferryl cation-radical, is an active intermediate in the catalytic 
cycle of all reactions catalyzed by CPO and is similar to that in other heme enzymes (104). 
The mechanism of Cpd I formation begins with the formation of Compound 0, as proposed 
by Chen et al. (Fig. 1.7) (105). An oxygen atom of hydrogen peroxide binds to the heme 
iron to form Fe(III)HOOH in two possible conformations, depending on whether Glu183 
hydrogen bonds to the hydrogen of the proximal or distal oxygen. However, Shaik et al. 
have shown that interactions with the distal hydrogen will not lead to the production of 
Cpd I, which leaves the first possibility. In this conformation, Glu 183 abstracts a proximal 
proton concomitantly with the movement of the –OOH group about the z-axis of the heme 
plane, resulting in formation of Cpd 0, in which protonated Glu 183 is hydrogen bonded to 
the distal oxygen. In the next step, Glu 183 protonates distal oxygen and upon water release, 
Cpd I is formed. Interestingly, the rate of Cpd I formation was shown to be only slightly 
dependent on the nature of the proximal ligand and independent of pH. However, the axial 
ligand might influence the stability and reactivity of Cpd I as was shown in cytochrome c 
peroxidase (106). 
        Another intermediate, Cpd II, is an oxo-ferryl species in the peroxidation pathway of 
CPO formed from Cpd I.  The X-ray absorption fine structure study by Green et al. has 
demonstrated that there are three species of Cpd II (107). It was postulated that the major 
species of Cpd II is in the protonated form, while the minor species is in the de-protonated 
form. The third species had a low yield (6%) and could not be assigned. A computational 
study by Lai et al. further explored the nature of Cpd II and assigned both the major and 
minor species to be iron(IV)-hydroxide species, differing only in hydrogen bonding with 
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either a water molecule or Glu 183 (108). The third species was tentatively assigned to be 
an iron(III)-hydroxide cation radical; however, no experimental data have confirmed the 
nature of Cpd II proposed by Green and Lai. 
 
Figure 1.7. Mechanism of CPO Compound I formation, the horizontal bold line represents 
the porphyrin ring (105). 
        Compound X is an intermediate in the halogenation pathway and is also formed from 
Cpd I. In the synthetic enzyme model, Cpd X was formed upon addition of Cl- to Cpd I to 
produce a ferric Fe-OCl- intermediate (109). Ferric Fe-OCl- was unable to chlorinate 
monochlorodimedone (MCD), which is a common substrate used in chlorination reactions. 
In contrast, the protonated species Fe-HOCl converted MCD into dichlorodimedone 
(DCD). That explains the reactivity of CPO at a low pH. The proposed reaction mechanism 
for chlorination reaction is shown in Figure 1.8 (110). 
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Figure 1.8. CPO-catalyzed chlorination mechanism (110). 
 
1.3.3 Reactions catalyzed by CPO 
        As mentioned earlier, CPO is one of the most versatile heme enzymes, capable of 
catalyzing a plethora of oxidation reactions. One-electron oxidations occur via the 
peroxidation pathway while two-electron oxidations occur via the halogenation, oxygen 
insertion, and dismutation pathways (111-113). Chloroperoxidase is able to oxidize a 
variety of substrates including amines, alcohols, alkenes, esters, anisoles, sulfides, and 
indoles (111, 114-126). 
1.3.3.1 One-electron oxidations 
        One-electron oxidations include peroxidation and oxidative de-halogenation 
reactions. Chloroperoxidase catalyzes peroxidations with less efficiency than classical 
peroxidases such as horseradish peroxidase and lignin peroxidase (127). Peroxidatic 
reactions occur on the surface of the enzyme (Fig. 1.9b) (112) via two one-electron transfer 
steps and involve formation of Cpd I and Cpd II intermediates (Reactions 1.1-1.4). In 
mechanisms of classical peroxidases (Fig 1.9), c was determined to be the rate-limiting 
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step, while for CPO, the rates difference between b and c is smaller than that in other 
peroxidases (127).  
 
 
Figure 1.9. Mechanistic routes of different types of reactions catalyzed by CPO: 
(a) halogenation, (b) phenol oxidation, (c) sulfoxidation (113). 
 
      2R-H + H2O2            R-R + 2H2O                          (1.1) 
a. Enzyme + H2O2        Cpd I + H2O                          (1.2) 
b. Cpd I + RH               Cpd II + R•                           (1.3) 
c. Cpd II + RH            Enzyme + R•                          (1.4) 
        Peroxidation reactions are pH-dependent with the highest rates achieved at acidic pH 
(128), which may indicate the requirement for Cpd II protonation and/or higher heme redox 
potential at low pH. Typical substrates in one-electron reactions are aromatic hydrocarbons 
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including ABTS (Fig. 1.10) and guaiacol that are commonly used to assay peroxidatic 
activities of enzymes (129, 130). Few data are available on the mechanism of peroxidation 
reactions catalyzed by CPO, and there is an ongoing debate regarding the site at which one-
electron oxidations take place. Casella et al. reported that phenols possessing bulky 
substituents and bearing free amino groups were poor substrates for oxidation by CPO 
(131). In addition, CPO stereoselectively catalyzed the L-isomer of N-acetyltyrosine, but 
not the D-isomer. These results indicate that CPO’s substrate selectivity is determined by 
size, charge, and the particular orientation of a molecule in the active site of the enzyme. 
Preference of smaller or para-substituted phenols as well as molecules lacking positive 
charge has been attributed to the rigidity of the access channel and the presence of positive 
amino acids in the active site, respectively. However, a more recent report by Manoj and 
Hager (112) argues that peroxidations most likely occur on the protein surface and not at 
the active site, on the basis of observed oxidations of bulky meta-substituted phenolics, 
benzylidene bis-dimethylaniline, and N′,N′,N′,N′-tetrabenzyl phenylenediamine, which are 
too big to fit into the active site of CPO. In addition, CPO treated with dialkyl 
pyrocarbonate is unable to perform reactions that require substrate binding to the active 
site, but retains its peroxidatic ability. Furthermore, different pH optima were reported for 
different substrates as well as for chloride-free and chloride-assisted peroxidations (132). 
These results suggest the possibility of two different peroxidation mechanisms and/or 
reaction sites. 
        Enzymatically catalyzed peroxidative reactions are of great interest to the public since 
they may be used to eliminate phenolic contaminants from water, degrade azo dyes utilized 
in textile industry, synthesize phenolic polymers as a healthier alternative to harmful 
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phenol-formaldehyde methods (133, 134), remove lignin degradation products generated 
by wood decomposition for bio-fuel production, etc. (135, 136). 
 
Figure 1.10. Oxidation of ABTS by CPO using hydrogen peroxide as an oxidant. 
       Another reaction that occurs via two one-electron transfer steps with Cpd I and Cpd II 
intermediates is the oxidative dehalogenation reported by Osborne et al. (137, 138) and 
further investigated by Murphy (139) and Diaz-Diaz (140). The substrates analyzed 
included trihalophenols and monofluorophenols (Fig. 1.11). In contrast to halogenation, 
where CPO is unable to use fluoride as a halogen source, CPO has been shown to catalyze 
defluorination. The discovery of this new reactivity of CPO has significant environmental 
implications. In particular, introduction of toxic chlorinated phenols into the environment 
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by industrial processes is a growing concern and effective methods of phenol degradation 
are needed. Thus, CPO has a potential to be used in catalytic bioremediation of toxic 
compounds and help create healthier environment. 
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Figure 1.11. Dehalogenation of (a) trihalophenol, where X = F-, Cl-, Br-, I-  and (b) 
4-fluorophenol. 
1.3.3.2 Two-electron oxidations 
        Two-electron oxidations include a variety of reactions such as halogenations, 
peroxygenations, peroxide dismutations, and have been proposed to occur at the active site 
of CPO, with the exception of halogenations (Figs. 1.9a and 1.9c) (112,113, 141, 142). The 
signature function of CPO is chlorination; however, it is also able to use bromide and iodide 
to halogenate various substrates as depicted in the reaction below, where X- includes Cl-, 
Br-, and I- : 
RH + H2O2 + X- + H+              R-X +2H2O                        (1.5) 
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Chloroperoxidase is unable to use hydrogen peroxide to oxidize fluoride ion since such a 
reaction is thermodynamically unfavorable (28). Halogenation involves formation of Cpd 
X and is most efficient at low pH with an optimum pH of 2.75 for CPO (132, 143). It has 
been debated whether halogenations occur in the active site of CPO or via diffusible 
intermediate(s). Manoj investigated those two possibilities in chlorination reactions of 35 
different substrates, and proposed that final chlorine transfer occurs outside the active site 
of CPO (141). This statement was derived from the observations that substrate size and 
topography had no significant effect on chlorination rates, and substrates larger that the 
active site dimensions were effectively chlorinated.  
        Substrates susceptible to halogenation by CPO include β-diketones, phenols (28), β-
keto acids (27), tyrosine, thyroglobulin (144), alkenes (143), alkynes (118), and aromatic 
hydrocarbons (145). A few examples are shown in Figure 1.12. It should be noted that 
halogenation occurs non-stereoselectively (146) and with a difference in an intermediate 
formation between chlorination/bromination and iodination reactions. In the former two 
types of reactions there is no formation of halogen molecule while in the latter reaction 
iodide is oxidized into iodine intermediate (28, 143).  
       Other two-electron oxidations include oxygen insertions and other oxidative reactions. 
Oxygen insertions can be divided into epoxidations, sulfoxidations, and hydroxylations, 
which occur stereo- and regio-selectively (124, 147, 148). Stereoselectivity arises from the 
fact that to gain access to CPO’s active site, the substrates need to properly orient in the 
channel that connects the surface of the enzyme to the heme pocket. Substrates for these 
two-electron oxidations include amines, alcohols, aldehydes, alkenes, alkynes, esters, 
anisoles, sulfides and indoles (111-112, 115-126).  
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Figure 1.12. Examples of CPO-catalyzed halogenations : (a) 1,3-
cyclopentanedione, (b) phenol, (c) alkene, (d) anthracene (aromatic hydrocarbon). 
        Epoxidation reactions occur stereoselectively via oxygen transfer from hydrogen 
peroxide or organic peroxide to form epoxide products (34): 
                         R R
' R R'
O
                               (1.6)            
In CPO, the nature of intermediates involved in epoxidation has not been elucidated yet; 
however, it has been suggested that epoxidation might occur via a dual pathway involving 
two different transition states (Fig. 1.13) (149). 
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`  
Figure 1.13. Possible transition states in epoxidation of cis-2-methylstyrene (149). 
        Chloroperoxidase catalyzes epoxidation of cis-disubstituted, 1,1-disubstituted, and 
tri-substituted alkenes that possess not more than 8 carbons, producing epoxides with the 
R-configuration as the major product. The highest enantiomeric excess and yields are 
obtained for cis-disubstituted olefins (Fig.1.14). Interestingly, trans-olefins and terminal 
alkenes were found to be poor substrates for CPO (147) as well as mono-substituted 
alkenes (150).  
a) 
O
  100%, ee 95% 
b)    
O
OEt
O
O
OEt                     67%, ee 93% 
Figure 1.14. Stereoselective epoxidation of (a) cis-heptene and (b) 3-methyl-3butenoate 
with yield and enantiomeric excess (ee) percentages. 
       Chiral epoxides are of great interest to pharmaceutical and chemical industries since 
they can be used as synthetic precursors to drugs and natural products (151). Currently, 
enantiopure drugs can be synthesized by high-cost multi-step organic methods which 
produce large amounts of toxic by-products and low yields of the compounds of interest 
(128, 152). Non-toxic, environment-friendly synthesis via enzymatic catalysis is thus a 
very promising alternative; however, there are some difficulties associated with the large-
scale utilization of CPO for epoxide production. 
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        One of the challenges in epoxidation reactions is determining the appropriate amount 
of the hydrogen peroxide oxidant to be used since large amounts of the oxidant cause 
oxidative damage to CPO. Another issue is the hydrogen peroxide dismutation ability of 
CPO (Eq. 1.7), which depletes the oxidant before significant yields of the desired product 
is produced.  Decreased product yield is the result of competition between hydrogen 
peroxide and the desired substrate for the particular reaction with Cpd I (153). Sometimes, 
other commonly used oxidants such as iodosobenzene and tert-butyl hydroperoxide can be 
substituted for hydrogen peroxide as is the case with functionalized cis-olefins (121). 
However, many simple unfunctionalized cis-alkenes require H2O2 for the epoxidation to 
occur (147). 
                      2H2O2     O2 + 2H2O                                                   (1.7) 
       Despite difficulties of epoxidations, there are several examples of successful 
applications of CPO in the production of special pharmaceutical compounds including 
synthesis of R-(-)-mevalonolactone (154) and (R)-dimethyl 2-methylaziridine-1,2-
dicarboxylate (155) that are important precursors for pentanoid compounds and alpha-
methylamino acids, respectively.  
       Another two-electron oxidation catalyzed by CPO is the stereoselective sulfoxidation 
of organosulfides (Eq. 1.8), producing mainly R-sulfoxides (142, 156-158):  
                               R R
'S R R'
O
S
                                     (1.8) 
Several substrates such as aromatic and β-carbonyl sulfides (157-160) were studied by 
different research teams. As with the epoxidation reaction, the size and nature of substrates 
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as well as the choice of the oxidant play an important role in product yield and enantiomeric 
excess (Fig. 1.15) (148, 160). Bulky substrates are either poorly oxidized or not oxidized 
at all. Para-substituted aryl alkyl sulfides or sulfides containing electron-donating groups 
on the benzene ring are more easily oxidized than ortho-substituted sulfides or sulfides 
containing electron-withdrawing groups. As for the oxidants, tert-butyl hydroperoxide and 
hydrogen peroxide are more effective than other oxidants in sulfide oxidations, giving 
increased product yields and enantioselectivity (157). Additionally, the manner in which 
the oxidant is introduced into the reaction system is critical for obtaining high yields of 
enantiopure products. The concentration of the oxidant must be kept low to prevent H2O2 
accumulation, which hinders the reaction by inactivating the enzyme. A low concentration 
of the oxidant can be achieved by continuously adding the oxidant at the rate of the initial 
reaction (125). 
        Many CPO-catalyzed sulfoxidations have environmental and biomedical significance. 
One of the examples of this utility is the removal of organosulfur from diesel fuel to reduce 
harmful effects on the environment. Chloroperoxidase converts organosulfides into the 
corresponding sulfones and sulfoxides, which can be effectively eliminated by distillation 
(152, 161). Another example is CPO-catalyzed synthesis of (R)-modafinil, which is used 
to treat sleep disorders and narcolepsy (162). 
        The next type of oxidation to be discussed will be hydroxylation, which can be 
stereoselective or nonstereoselective, depending on reaction conditions.  Additionally, 
hydroxylation most likely occurs via the oxygen insertion pathway as determined by Zaks 
and Dodds (117). A dual pathway for CPO-catalyzed hydroxylations was proposed based 
on hydroxylations catalyzed by P450s (Fig. 1.16) (149). The first one involves an oxo-
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ferryl species with transition state 20 while the other one involves ferric hydroperoxide 
species with transition state 21 (Fig. 1.16). However, the mechanism of hydroxylation 
remains to be elucidated. 
 
a)     
S
O
S
H3C CH3
O
CH3
O
H3C              100%, ee 99% 
b) 
S
O
S
Et
O
Et
O
            31%, ee 92% 
c) 
S
O
S
CH3 CH3
                98%, ee 91% 
d)  
S
O
S
Pr Pr
                53%, ee 5% 
e)  
S
O
S
CH3 CH3
O2N O2N     10%, ee 80% 
 
Figure 1.15. Stereoselective sulfoxidation of (a,b) beta-carbonyl sulfides and (c,d,e) aryl 
sulfides with yield and enantiomeric excess (ee) percentages. The nature and size of the 
substrate influence the yield and ee values. 
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Figure 1.16. Dual mechanism proposed for CPO-catalyzed hydroxylations (149). 
        As with other oxidation reactions, the oxygen in hydroxylation comes from an oxidant 
such as hydrogen peroxide (124). In contrast with epoxidation and sulfoxidation reactions, 
hydroxylation products can have either R (2-phenethyl alcohol) or S (1-phenyl-1-propanol) 
configuration (117). Among the substrates of CPO that undergo hydroxylation are p-
methylanisole and p-ethylanisole (124), functionalized and unfunctionalized acetylenes 
(121), cyclic conjugated dienes (163, 164), and R-(+)-limonene that belongs to 
monoterpenes (165). As with aryl sulfides, benzylic compounds containing ortho-
substitutions are poorly hydroxylated or not hydroxylated at all. The degree to which the 
reaction proceeds is determined by substrate oxidation potential, nature of substituents, and 
steric requirements (124).  
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       The stereoselectivity of CPO-catalyzed hydroxylation is dependent on the nature of 
the substrate. In reactions with 1,3-cyclohexadienes, the product of the reaction with 2-
hydroxyphenol has an enantiomeric excess of 78% while 1,3-cyclohexadiene diacetate is 
converted into a racemic mixture (Fig. 1.17) (163). The presence of chloride in the reaction 
may influence the enantiomeric excess as observed with the R-(+)-limonene, which is 
converted into a single enantiomer (99%) when there is no chloride, while a racemic 
product is formed if chloride is present (Fig. 1.18) (165). The loss of stereoselectivity when 
chloride is present suggests that chloride ions may be converted to hypochlorite, which in 
turn oxidizes limonene without stereoselectivity. Thus, CPO-catalyzed hydroxylations are 
less stereoselective than epoxidations or sulfoxidations. However, with carefully controlled 
conditions, useful enantiopure products can be obtained, such as during halo-hydroxylation 
of chloropropene and allyl alcohol to prepare chiral precursors for agrochemical and 
pharmaceutical industries (166). The side reactions that need to be controlled include 
further oxidation of alcohols to aldehydes and oxidant dismutation (122).  
        In addition to the reactions described above, CPO is able to catalyze the oxidation of 
different monoterpenes in the presence of halide to yield halohydrins (167), regio- and 
stereoselective bromohydration of glycals to produce 2-deoxy-2-bromo saccharides (168), 
oxidation of unsubstituted and substituted indoles to yield oxindoles (125, 169, 170), N-
oxidation of arylamines to give nitroso metabolites (111, 169, 171), oxidation of alcohols 
to aldehydes (116), and oxidation of conjugated dienoic esters to yield a variety of products 
(123). Many of the above compounds can be converted into chemicals that serve as 
intermediates in the synthesis of flavors, fragrances, and drugs (125, 167).  
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Figure 1.17. Hydroxylation of 1,3-cyclohexadienes catalyzed by CPO. The nature and size 
of the substrate influence the yield and ee values. 
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Figure 1.18. Oxidation of R-(+)-limonene catalyzed by CPO in the presence and absence 
of KCl. 
1.3.4 Ligand-binding properties 
        Despite similarities between spectroscopic properties of CPO and P-450cam (172), in 
terms of ligand-binding properties, CPO has a closer relationship to peroxidases. Many 
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ligands except for the halides, acetate, and nitrate, form low-spin complexes with CPO 
(173, 174). Since weakly acidic ligands with pKa 3.2-9.14 (cyanide, pyridine, imidazole, 
fluoride) bind to ferric CPO in their neutral form and lose their proton upon ligation, the 
binding affinity is decreased above their pKa. In contrast, very acidic ligands with negative 
pKa (thiocyanate, nitrate, chloride, bromide, and iodide) seem to bind in their anionic form 
and display varying affinities in pH range 2-7. For neutral ligands such as carbon monoxide 
and n-butyl isocyanide, no changes in affinity were observed at various pH. It has been 
suggested that for ligand binding to ferric CPO, an amino acid with a pKa less than 2 is 
involved, while a group with the pKa of 5.5 is involved in ligand binding to ferrous form 
of the enzyme (174).  
        Carbon monoxide and cyanide have high affinities for CPO and most heme proteins 
in general, and make open crevice structures more stable (175). Interestingly, when 
diatomic and triatomic ligands bind in the distal site of CPO, they do so without requiring 
movement of the distal residues to accommodate those ligands (176). Instead, the distal 
Glu 183 interacts with ligands either electrostatically or via hydrogen bonding. This 
becomes very important during the formation of Cpd I when hydrogen peroxide binds to 
the heme, and Glu 183 acts as an acid-base catalyst to promote O-O scission and release of 
water (176). 
1.4 Spectroscopic properties of heme proteins 
        Electronic absorption, resonance Raman (RR), nuclear magnetic resonance (NMR), 
and circular dichroism (CD) spectroscopies are frequently used to investigate heme 
proteins. Electronic absorption spectroscopy or UV-Vis spectrophotometry, can be used to 
investigate electronic structure of heme and its environment, i. e., the coordination and spin 
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state of the heme iron. A typical absorbance spectrum of a heme protein (Fig. 1.19) (177) 
includes a peak at around 400 nm called the Soret band and minor peaks in 500-700 nm 
region called Q bands that result from transitions in the porphyrin (Fig. 1.20) (178). 
 
Figure 1.19. A typical electronic absorption spectrum of a heme protein (177). 
        The Soret and Q bands both arise from π–π* transitions and can be explained using 
the Gouterman four orbital model that was proposed in the early 1960s (178). According 
to this model, transitions between two highest occupied molecular orbitals (HOMOs) and 
two lowest unoccupied molecular orbitals (LUMOs) produce these absorption bands and 
their relative energies depend on the substituents on the porphyrin ring and the identity of 
the metal center. The Soret peak is a result of a strong transition to the second excited state 
(S2) while minor peaks are the result of weak transitions to the first excited state (S1). 
Furthermore, the Q band that results from a transition from the resting state to the S1 
vibrational ground state is called the α band while the Q band due to transitions to higher 
vibrational levels in the S1 is called the β band and appears at slightly lower wavelengths 
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than the α band.  The intensities of the α and β bands relative to each other can serve as a 
measure of how close in energy the a2u and a1u orbitals are. For instance, if both orbitals 
are very similar in energy, the degree of orbital mixing will be large. In this case, the α 
band intensity will be small and the α/β intensity ratio will be small as well. On the contrary, 
if the a2u and a1u orbitals have very different energies, the α/β intensity ratio will be larger 
because of the smaller degree of orbital mixing (179). 
 
Figure 1.20. The Gouterman four orbital model. 
        Other interactions that can be observed with UV-Vis spectrophotometry include 
porphyrin - iron interactions. Since ferrous iron has filled d π orbitals (d6), ferrous heme is 
a hypsoporphyrin in which the interactions between iron d π (d(xz), d(yz)) and porphyrin 
π* (a1u) orbitals are significantly stronger.  These strong interactions result in a larger 
porphyrin π to π* (a2u to a1u) energy difference, causing the hypsochromic (blue) shifts in 
the electronic spectra (Fig. 1.21). In contrast, in regular metalloporphyrins with closed d-
shells (d0 or d10), the d π metal orbitals have little effect on the π to π* energy separation in 
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porphyrin electronic spectra because of their low energy (180).  
 
Figure 1.21. Interactions between iron d π (d(xz), d(yz)) and porphyrin π* (a1u) orbitals. 
        Resonance Raman spectroscopy is used to monitor structural changes in the heme 
upon ligand binding and electron transfer (181). In the Raman spectrum of a heme protein, 
several bands in the high-frequency region are associated with vibrations of porphyrin 
substituents while bands in the low-frequency region arise from vibrations of the axial 
ligands. Thus, resonance Raman spectroscopy can be used to investigate the structure of a 
heme center, as well as the spin of the iron and the nature of the proximal and distal ligands 
(182). 
        Proton NMR is another powerful technique that allows structural characterization of 
hemoproteins. Although it has been challenging to assign all heme protons in the NMR 
spectrum for CPO, it is a useful technique for verifying the proximal ligand substitutions, 
as well as assessing other important residues in the active site of CPO (183). The broad 
resonances make it difficult to analyze a proton NMR spectrum of a native high-spin heme 
protein. Thus, the cyanide-bound low-spin protein complex may be analyzed to obtain 
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information on electronic and molecular structural properties.  
        Circular dichroism can be utilized in the determination of protein alpha-helical and 
beta-sheet content as well as for monitoring of secondary and tertiary structural changes in 
mutant proteins or protein-ligand complexes. Several programs, such as CONTINLL (184, 
185), SELCON3 (186, 187), CDSSTR (188-190), VARSLC (188, 189), and K2D (191) are 
available for estimation of the protein secondary structures. The algorithms differ in the 
number and nature of the reference protein sets used in analysis, thus one method might be 
more suitable than others for a particular protein. As for tertiary structure CD, it is useful 
for confirming the integrity of protein domains expressed separately, investigating protein 
stability under changing conditions, and observing structural alterations in mutants or upon 
ligand binding. For heme proteins, CD may also provide information on changes in the 
environment of the heme group (192). Additionally, it is possible to assign a protein to a 
particular class (all alpha, all beta, alpha+beta, alpha/beta, denatured) based on the method 
developed by Venyanimov and Vassilenko (193), which is especially useful for new 
understudied proteins. 
1.5 Site-directed mutagenesis to study structure-function relationships in heme 
proteins 
        Heme enzymes are attractive targets for protein engineering because of their catalytic 
diversity. There are four approaches to constructing heme enzymes with desired catalytic 
and substrate-binding properties: modification of the heme group, exon shuffling of 
hemoglobin, directed evolution, and rational design (194). In my study, I employ the latter 
approach using site-directed mutagenesis to explore how changes in the proximal active 
site affect biochemical properties of CPO. Many heme protein mutants have been prepared 
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using site-directed mutagenesis to gain insights into the role of the heme environment in 
catalysis and substrate specificity. The results of several of those studies are summarized 
in Table 1.3. 
Table 1.3. Effects of distal and proximal active site mutations on catalytic activities of 
some heme proteins. 
Protein/Mutation Activity Changes References 
Mb 
F43H/H64L 
(distal His relocation) 
 
 
 
L29H/H64L 
(distal His relocation) 
 
 
 
H64D 
(distal His substitution) 
 
 
 
H93Y 
(proximal His substitution) 
 
Increased peroxidase, epoxidase, and 
sulfoxidase activities, increase in heme 
iron-distal His distance from 4.3Å to 5.7Å 
(similar to peroxidases) 
 
Decreased peroxidase activity, increase in 
heme iron-distal His distance from 4.3Å 
to 6.6Å (too far for efficient H2O2 
activation) 
 
Increased peroxidase activity, 
replacement with aspartate that can act as 
acid-base catalyst in formarion of Cpd I 
 
 
Decrease in catalase activity, possibly 
poor H2O2 binding 
 
(195) 
 
 
 
 
(195) 
 
 
  
 
(195) 
 
 
 
 
(196) 
 
HRP 
R38H, R38H/H42V 
(distal His relocation) 
 
 
H42E, H42Q    
(distal His substitution) 
 
              
F41A 
(increase in heme access) 
 
 
N70V, N70D 
 
Decreased peroxidase activity, but 
increased sulfoxidation and epoxidation, 
better access  to the active site 
 
Decreased peroxidase activity, 
suboptimal orientation of E lacking H-
bonding with N70 
 
Similar peroxidase activity to wild-type 
(WT), increased sulfoxidation and 
epoxidation 
 
 
(197) 
 
 
 
(198) 
 
 
 
(199) 
 
 
 
(200) 
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(H-bond disruption) Decreased peroxidation, deletion of H-
bonding between H42 and N70 
 
CcP 
W51H/H52L 
W51H/H52W 
(distal His relocation) 
 
H52D, H52E, H52N, H52Q 
(distal His substitution) 
 
H175E 
(proximal His substitution) 
 
Decreased catalytic activity because of the 
slower reaction with H2O2 
 
 
Decreased activity because of the slower 
rates of Cpd I formation 
 
Increased activity 
 
(201) 
 
 
 
(202) 
 
 
(106) 
P450cam 
T96A, T96F 
(distal Tyr substitution) 
 
C357U 
 
P450175A1 
L80H, L80Q 
(distal Leu substitution) 
 
 
Increased hydroxylation 
 
 
Decreased oxygenase activity 
 
 
Increased peroxidase activity 
(pH dependence, increase in basicity of H 
and Q and pKa increase of peroxide more 
active at basic pH) 
 
(203) 
 
 
(204) 
 
 
(205) 
CPO 
E183H 
(distal Glu substitution) 
 
Decreased chlorination and dismutation, 
increased epoxidation. 
 
(206) 
 
        From the data above, it is evident that there are multiple factors that regulate redox 
potentials and catalytic activities of heme enzymes.  These factors include the nature of the 
proximal ligand, the heme iron-ligand distance, the nature of a distal acid-base catalyst, 
hydrogen bonding networks in both distal and proximal heme pockets, polarity of the active 
site, and the accessibility of the active site by substrates.  
        To better understand structure-function relationships in this class of proteins, several 
mutagenesis studies were performed on such heme proteins as myoglobin, horseradish 
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peroxidase, and cytochrome c peroxidases. Despite the fact that CPO from C. fumago was 
discovered in 1966, it is still poorly understood how CPO directs catalysis of such a broad 
range of reactions and substrates. There is much debate about the importance of the 
proximal thiolate ligation in CPO as well as contributions of other structural features in 
defining biochemical properties of this enzyme.  
        In my work, I utilized site-directed mutagenesis to introduce single or double amino 
acid substitutions in the active site of CPO in order to explore their roles in the structure 
and catalysis of this protein. I concentrated my attention on the proximal region of the heme 
pocket, and investigated the importance of Cys 29 as well as the hydrogen bond network 
between Arg 26 – Asn 37 and Ala 27 – Asn 33 for biochemical properties of CPO. Since 
there is no consensus on the role of Cys 29 in CPO catalysis, I chose to substitute Cys 29 
with a His to imitate proximal ligation of a classical peroxidase and investigate the 
properties of the mutant. Furthermore, I replaced Arg 26 and Asn 33 with Ala in R26A, 
N33A, and R26A/N33A mutants to disrupt the hydrogen bond network. It is reasonable to 
suggest that these hydrogen bonds are important for maintaining the particular tertiary 
structure of CPO, and possibly, for catalysis. Since no data are available on the role of 
hydrogen bonds in the proximal pocket of CPO, I chose to investigate how removal of 
some or all hydrogen bonds in this network would affect the biochemical properties of this 
enzyme. The following chapters will present my findings on the characterization of C29H, 
C29H/C79H, C29H/C79H/C87H, R26A, N33A, and R26A/N33A CPO mutants, compare 
their biochemical properties to those of WT CPO, and discuss factors that play a significant 
role in the structure and function of CPO. 
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CHAPTER II. 
THE ROLE OF THE PROXIMAL LIGAND IN CPO, A LONG LASTING 
DEBATE 
2.1 Background 
        In heme proteins, the nature of the axial ligand together with active site polarity and 
electrostatic interactions influence the heme redox potential, which in turn, affects 
reactivity (207). Common proximal ligands include histidine (most peroxidases), cysteine 
(CPO, UPOs, and P450s), and tyrosine (catalases) (49, 63, 64, 67, 71). The role of the 
proximal thiolate ligand in defining the biochemical properties of heme proteins has been 
much debated (48, 172, 208-210). It has been suggested that the heme proximal ligation to 
a cysteine is responsible for the Soret peak near 450 nm for ferrous CPO – carbon monoxide 
(CO) complex, similarly to CO-bound P450 (172, 208). By comparison, carbon monoxide 
complexes of heme proteins with His as a proximal ligand absorb near 420 nm (106, 196). 
In addition, it has been postulated that thiolate ligand plays a crucial role in the catalytic 
diversity of CPO and provides it with the ability to perform chlorination reactions, while 
other peroxidases with the imidazole proximal ligation either lack or have a very low level 
of chloride oxidation ability (48, 209, 210). 
        Many site-directed mutagenesis studies have been done on heme proteins with 
imidazole and thiolate proximal ligation to understand the role of the proximal ligand in 
catalysis of heme proteins and the results of those studies are summarized in Table 2.1. 
From the data in Table 2.1, it is evident that substitutions of native proximal ligands 
dramatically change the catalytic abilities of heme proteins. However, it is difficult to 
clearly define ligand-function relationships. For example, upon substitution of the proximal 
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His with a Cys in myoglobin, oxygen insertion reaction rates are increased (196, 211). 
However, similar substitution in CcP results in decreased overall activity of the enzyme 
(106). Furthermore, replacement of the proximal Cys with a His in P450s results in a 
complete loss of oxygenase activity (212-214). However, similar substitution in CPO 
results in only slightly decreased epoxidation rates (215).  
Table 2.1. Effects of proximal active site mutations on catalytic activities of some heme 
proteins. 
Protein/Mutation Activity Changes References 
Mb 
H93C 
 
 
H64G/H93C, 
H64V/H93C 
 
H93Y 
 
Increased sulfoxidation and epoxidation 
rates, decreased dismutation 
 
Slightly decreased sulfoxidation rates 
because of the hydrophobic distal site 
 
Decrease in catalase activity possibly 
because of the poor H2O2 binding 
 
(196, 211) 
 
 
(211) 
 
 
(196) 
 
HRP 
H170A 
 
Loss of peroxidase activity 
 
(199) 
CcP  
H175Q 
 
H175E 
 
H175C 
 
Similar activity to WT 
 
Increased activity 
 
Significant decrease in activity 
 
(106) 
 
(106) 
 
(106) 
P450 2B4 
A298E/C436H 
P450cam 
C357H 
 
 
C357U 
 
Increased peroxidase activity while 
complete loss of oxygenase activity 
 
Loss of oxygenase activity 
Significant reduction in hydroxylation 
activity 
 
Decreased oxygenase activity 
 
(212) 
 
 
(213, 214) 
 
 
 
(204) 
CPO 
C29H 
 
Chlorination, dismutation, peroxidation, 
and epoxidation slightly decreased 
 
(215) 
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        In the present study, I replaced proximal thiolate ligand in CPO with a His to mimic 
the ligation in classical peroxidases using site-directed mutagenesis. I utilized such 
spectroscopic techniques as proton NMR, CD spectroscopy, and UV-Visible 
spectrophotometry to investigate how the Cys 29→His mutation affects structural and 
catalytic properties of CPO to gain insights into the role of proximal Cys in CPO and other 
thiolate proteins.  
2.2 Experimental procedures 
2.2.1 Materials 
        A filamentous fungus, Aspergillus niger, was chosen for expression of the mutant 
CPO since expression in C. fumago produces WT CPO background that interferes with 
characterization of the mutant. The MGG029 strain A. niger was purchased from American 
Type Culture Collection. The plasmid coding for WT CPO (pCPO3.I-Amds) and co-
transformation plasmid containing PyrG selection marker (pAB4-1) were purchased from 
TNO Microbiology and Systems Biology, Netherlands. The QuikChange II XL site-
directed mutagenesis kit and PfuUltra HF DNA polymerase were purchased from 
Stratagene (La Jolla, CA). Restriction enzymes were obtained from New England Biolabs 
(Ipswich, MA). Purified oligonucleotide primers were purchased from Eurofins MWG 
Operon (Huntsville, AL). De-ionized water for all experiments were prepared freshly by 
Milli-Q Biocel (Millipore, Billerica, MA). All other chemicals and materials were 
purchased from Fisher Scientific (Waltham, MA) unless otherwise stated. 
2.2.2 Construction of C29H CPO gene and plasmid propagation 
        To probe the structural, spectroscopic, and functional role of proximal ligand in CPO, 
the C29H mutation was introduced into the pCPO3.I – AmdS (a PUC19-based 14-kb 
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plasmid, Fig. 2.1) via polymerase chain reaction (PCR) amplification using the 
QuikChange II XL site-directed mutagenesis kit. The PCR reaction was carried out in 
Eppendorf thermal cycler (Mastercycler gradient) using PfuUltra HF DNA polymerase. 
The amounts of reagents used in a PCR reaction (total volume = 50µL) are listed in Table 
2.2. The following primers were used to introduce the C29H mutation: 
Coding strain - C29H primer 1 
5’- CTACCGACTCTCGTGCTCCTCACCCAGCTCTGAACGCTCTTG - 3’ 
Non-coding strain – C29H primer 2 
5’- CAAGAGCGTTCAGAGCTGGGTGAGGAGCACGAGAGTCGGTAG - 3’ 
 
 
Figure 2.1. pCPO3.I-AmdS plasmid containing A. niger glucoamylase promoter (PglaA), 
CPO gene from C. fumago, A. nidulans anthranilate synthetase terminator (TtrpC), and A. 
nidulans acetamidase gene (AmdS) as a selection marker allowing growth on acetamide as 
the sole source of nitrogen. 
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Table 2.2. Reagents used in the PCR reaction. 
 
Reagent Amount  
10Xreaction buffer 5 µL 
pCPO3.I – AmdS  1 µL 
Primer 1 125 ng 
Primer 2 125 ng 
dNTP mix 1 µL 
QuikSolution reagent 3 µL 
PfuUltra HF polymerase 1 µL 
DpnI 1 µL 
 
The PCR was performed using the following steps: 
1 cycle → 95°C for 1 minute 
18 cycles → 95°C for 50 seconds (denaturation) 
                     60°C for 50 seconds (annealing) 
                     68°C for 14 minutes (extension) 
1 cycle → 68°C for 7 minutes 
The DNA product was digested with Dpn I restriction endonuclease to eliminate native 
plasmid. Mutated plasmid was propagated in E. Coli (DH5-α strain), and C29H mutation 
was confirmed by DNA sequencing (Fig. 2.2). Before transformation, both pCPO3.I and 
pAB4-1 (Fig. 2.3) were verified by DNA digestion and electrophoresis (Fig. 2.4). 
 
Figure 2.2. C29H pCPO sequencing results. 
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Figure 2.3. pAB4-1 plasmid containing A. niger PyrG gene as a selection marker allowing 
fungal growth without uridine supplementation. 
 
 
Figure 2.4. DNA electrophoresis. Restriction digestion of pCPO and pAB4-1. Lanes 1-4: 
pCPO3.I-AmdS, lanes 5-8 pAB4-1, lanes 1 and 5 – undigested DNA, lane 2 – HindIII, lane 
3 – AflIII, lane 4 – Hind III and AflIII, lane 6 – XbaI, lane 7 – BamHI, lane 8 – XbaI and 
BamHI. 
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2.2.3 Transformation of Aspergillus niger with C29H pCPO and mutant selection  
        The pCPO3.I-C29H was co-transformed with pAB4-1 into the protease deficient 
MGG029 strain of A. niger (prtT gla::fleor pyrG) using procedures described previously 
(97, 216) with the following modifications. Brown conidiospores were inoculated in 50-
mL minimal medium (MM) containing 0.5% yeast extract, 0.5% Casamino acids, 5% 
maltose, 1% glucose, 70mM NaNO3, 7 mM KCl, 6 mM KH2PO4, 6 mM K2HPO4, 2 mM 
MgSO4, 10 mM uridine, 25µL of carbenicillin (100 mg/mL stock), 50uL of the Hutner 
trace elements solution (217). The mini-culture was incubated at 250 rpm and 37°C for 1 
day and then at 30°C until white-yellow mycelium is observed (2-5 days). After disruption 
of the mycelium with a homogenizer, the culture was transferred to 1-L MM and incubated 
at 30°C and 250 rpm for 16-20 hours followed by protoplast preparation and DNA 
transformation using polyethylene glycol as described previously (216). Successful 
transformants were selected on polyacrylamide plates lacking uridine supplementation and 
used to express the mutant protein. 
        Each clone from the acrylamide plates was inoculated in 50-ml MM lacking uridine 
and yeast extract, and incubated at 250 rpm and 22°C for 1 week. The ABTS assay, 
described below, was used to determine the clone with the highest protein yield, which was 
used to set up large scale protein expression.  
2.2.4 Expression and purification of C29H CPO 
       The A. niger spores (1 plate per 1 L medium) were inoculated into 48-L MM lacking 
uridine and yeast extract and containing 10% fructose, carbenicillin (50 mg/L), and 100 
µM δ-aminolevulinic acid. Cultures were incubated at 250 rpm and 25°C for 3 days and 
then at 22°C for 4 more days. Then, the medium was filtered through glass fiber filter 
46 
 
circles G6 and concentrated down to 50 mL in the Amicon stirring pressure cells. 
Concentrated sample was dialyzed against 25 mM phosphate buffer, pH 5.9 and filtered 
through 0.45 µm membrane. 
        Mutant CPO was purified using AKTA prime chromatography system. All buffers 
used during purification were filtered through 0.45 µm membrane and de-gassed for 15 
minutes. The protein sample (50 mL) in 25 mM phosphate buffer, pH 5.9  was filtered 
through 0.45 µm membrane and applied onto a 100-mL column packed with 50 mL of 
diethylaminoethanol (DEAE) sepharose resin, and washed with 25 mM phosphate buffer, 
pH 5.9 while gradually increasing NaCl concentration. The C29H CPO eluted at 
approximately 30% 0.5 M NaCl. Fractions with Reinheitzahl (RZ) values (A420/A280) 
above 0.7 were combined and concentrated down to about 1 mL using Millipore 30,000 
centrifugal filter unit. The sample was filtered through 0.45 µm membrane and applied 
onto a gel filtration column containing 500 mL of Sephadex G75 resin and eluted with 25 
mM phosphate buffer, pH 5.9 (Fig. 2.5).  
 
Figure 2.5. C29H CPO sample loaded on a gel filtration column. 
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Fractions with RZ values between 1.2 – 1.5 were used in all subsequent studies. Purity of 
the mutant CPO was assessed by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) (Fig. 2.6). 
 
Figure 2.6. SDS-PAGE. WT and C29H CPO. Lanes 1 and 2 – C29H, lane 3 – WT CPO. 
 
2.2.5 Spectroscopic characterization of C29H CPO  
        Structural characterization of C29H CPO was performed using 600MHz nuclear 
magnetic resonance spectrometer, JASCO CD spectrometer, and VARIAN UV-Vis 
spectrophotometer (Cary 300 Bio). 
2.2.5.1 Proton nuclear magnetic resonance spectroscopy 
        Proton nuclear magnetic resonance (NMR) spectroscopy was used to confirm C29H 
mutation of CPO. A 600-MHz NMR spectrometer was used to investigate the NMR 
spectral properties of the ferric low-spin cyanide complexes of C29H CPO in comparison 
with cyanide complexes of HRP and WT CPO. HRP was chosen for comparison since it is 
a classical peroxidase with the imidazole proximal ligation. The spectra of the enzyme-CN- 
complexes in deuterated phosphate buffer were taken at room temperature.  I chose to work 
with dCPO-CN complexes since the high-spin nature of WT dCPO produces broad spectral 
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resonances providing limited information about the structure of the protein. When bound 
to cyanide, heme iron in WT CPO converts to a low spin, and protein-CN complex 
spectrum can provide more information about structural properties of the active site than 
the native ferric form of the protein.    
        The spectra of a 0.8 mM cyanide-bound C29H CPO (RZ=1.2), 1.0 mM WT CPO, and 
1.0 mM HRP were collected in a 5-mm NMR tubes. Protein samples were exchanged with 
deuterated 25 mM potassium phosphate buffer before analysis using Centricon from 
Amicon. Protein-cyanide complexes were prepared by addition of an excess amount of 
freshly prepared 1M KCN in deuterated phosphate buffer, pH 5.9. The concentration of the 
C29H sample was estimated from the theoretical extinction coefficient of 44,015 M-1 cm-1 
at 280 nm as calculated by ProtParam tool (expasy.org). For WT CPO, the signals in the 
downfield region represent protons from amino acid residues in the proximal and distal 
sites of CPO and heme substituents while upfield shifts belong to beta-protons of amino 
acid residues near the center and the heme propionate and vinyl groups (183). 
2.2.5.2 Circular dichroism spectroscopy 
        The CD spectra of 1 µM C29H and WT CPO in 5 mM sodium acetate buffer, pH 5.5 
were collected in the 190-260 nm range at room temperature using 5-mm quartz cuvettes. 
Three spectra were averaged for each protein. The secondary structures were determined 
using CDSSTR method and reference #4 (218). CDSSTR is a program that performs 
calculations of the secondary structures using a particular number of proteins in the 
reference set. Those proteins that do not reflect characteristics of the test protein are 
removed from the basis set, and secondary structures are assigned by the singular value 
decomposition algorithm (DICHROWEB). 
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2.2.5.3 UV-Visible spectrophotometry 
        The UV-Vis absorption spectra of C29H and WT CPO in phosphate buffer, pH 5.9 
were collected in the 250-700 nm range at room temperature using 1-cm quartz cuvettes. 
Three spectra were averaged for each protein. To study the effect of pH, the spectra of 
C29H and WT CPO in 100 mM phosphate-citrate buffer or 100 mM phosphate buffer (pH 
2.5 – 10.0) were collected using 1-cm quartz cuvettes at room temperature. Buffer 
exchange was performed using PD-10 column from GE Healthcare Life Sciences. 
2.2.6 Ligand binding study  
        Cyanide (CN-) and carbon monoxide (CO) are known substrates for WT CPO (219, 
220). The absorption spectra of C29H and WT CPO in 25 mM phosphate buffer, pH 5.9 in 
the absence and presence of substrates were collected using 1-cm quartz cuvettes. The 
spectra were recorded in 250 – 700 nm range at room temperature using UV-Vis 
spectrophotometer. The final concentration of cyanide in the sample was 100 mM. In 
CN- binding study, the spectra were collected upon initial addition of the substrate and after 
15-minute incubation of the sample at room temperature. For CO binding, WT and C29H 
CPO were reduced with sodium dithionite and purged with CO for 1 minute. To eliminate 
the possibility of the proximal His to Cys switch, I also prepared C29H/C79H and 
C29H/C79H/C87H CPO as described in sections 2.2.2-2.2.4 and performed CO binding 
study with those two mutants as well. The primers used to construct C29H/C79H and 
C29H/C79H/C87H CPO are given in Fig. A1. 
2.2.7 Enzymatic activity assays 
        All reactions were initiated by the addition of hydrogen peroxide (except for catalase 
assay) and monitored for 180 seconds with a UV/Vis spectrophotometer at room 
50 
 
temperature. The initial rates of reactions were calculated from the linear portions of the 
reaction curves.  
2.2.7.1 Peroxidation assay (ABTS)  
        Peroxidase activity of CPO was measured by the oxidation of ABTS that is commonly 
used as a substrate to estimate peroxidation activity of heme enzymes (221). The reaction 
system consisted of either WT or mutant CPO in 100 mM phosphate-citrate buffer (pH 
2.75 - 6.0) containing 36.8 µM ABTS. After H2O2 (3.6 mM) addition, the reaction was 
monitored for the formation of oxidized ABTS at 405 nm. Protein amounts used for the 
assay at various pH are listed in Table 2.3. The activity of CPO was decreased at higher 
pH; therefore, larger amounts of protein were used to detect peroxidation. 
Table 2.3. Protein amounts used in ABTS assay at different pH. 
pH WT (µM) C29H (µM) 
2.75 0.003 0.03 
3.0, 3.25, 3.5 0.03 0.03 
4.0 0.1 0.03 
4.5 0.5 0.1 
5.0, 5.5 1.0 0.1 
6.0 2.0 0.1 
 
2.2.7.2 Chlorination assay (MCD) 
        The MCD assay was used to determine the chlorination activity of CPO that catalyzes 
conversion of MCD into DCD (222). The reaction system consisted of either WT or C29H 
CPO in 100 mM phosphate-citrate buffer (pH 2.75, 3.0, 3.5, 4.0, 4.5, 5.0) containing 20 
mM KCl and 0.17 mM MCD. After H2O2 (2.2 mM) addition, the reaction was monitored 
at 278 nm, at which MCD absorbs. In the pH range 2.75-4.0, 0.005 µM WT CPO was used 
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in the assay while 0.05 µM was used at pH 4.5 and 5.0. As for C29H CPO, 0.6 µM mutant 
protein was used in MCD reactions at all pH. 
2.2.7.3 Catalatic assay  
        Catalatic activity was measured by monitoring decomposition of hydrogen peroxide 
(34). The reaction system consisted of 0.05% hydrogen peroxide in either 100 mM 
phosphate buffer, pH 2.4 or 100 mM phosphate-citrate buffer (pH 3.0, 3.5, 4.0, 4.5, 5.0, 
5.5, 6.0). After either 0.5 µM WT or 0.5 µM C29H CPO was added, the reaction was 
monitored at 240 nm.  
2.2.7.4 Epoxidation assay (styrene)  
        Styrene epoxidation assay (15) was performed in 100 mM phosphate-citrate buffer 
(pH 2.75, 3.0, 3.5, 4.0, 4.5, 6.0, 7.5) containing 0.3 mM styrene and either 0.3 µM WT or 
C29H CPO. After addition of 2.2 mM H2O2, the reaction was monitored at 262 nm, at 
which styrene absorbs.  
2.2.7.5 Calculations of specific activities  
        Specific activities (SA) were calculated using equation 2.1 while the change in the 
amount of a substrate or product over time was calculated using equation 2.2, where A is 
absorbance, ε is the extinction coefficient at a specific wavelength, b is the length of a 
pathway, and c is the concentration of the substrate or product. 
 
𝑆𝑆𝑆𝑆 =  µ𝑚𝑚𝑚𝑚𝑚𝑚 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 𝑚𝑚𝑠𝑠 𝑝𝑝𝑠𝑠𝑚𝑚𝑝𝑝𝑠𝑠𝑝𝑝𝑠𝑠/𝑠𝑠𝑠𝑠𝑝𝑝
µ𝑚𝑚𝑚𝑚𝑚𝑚 𝑠𝑠𝑒𝑒𝑒𝑒𝑒𝑒𝑚𝑚𝑠𝑠                              Eq. 2.1 
 
 
                                𝑆𝑆 =  𝜀𝜀𝜀𝜀𝜀𝜀,                                                  Eq. 2.2 
 
The extinction coefficients used to calculate substrate or product concentration change are 
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listed in Table 2.4. 
Table 2.4.  Extinction coefficients of oxidized ABTS, MCD, hydrogen peroxide, and 
styrene. 
Substrate or product Wavelength Extinction coefficient 
(mM-1cm-1) 
Oxidized ABTS 405 nm 36.8 
MCD 278 nm 12.2 
H2O2 240 nm 0.0436 
Styrene  262 nm 0.6225 
 
The styrene extinction coefficient at 262 nm was determined to be 0.6225 ± 0.0781    mM-
1cm-1 from the slope of a plot of absorbance versus concentration (from 3 trials)  (Fig. 2.7). 
Styrene was dissolved in 100 mM phosphate-citrate buffer, pH 3.25. Since styrene 
absorbance decreases with time because of its poor solubility in aqueous solutions, all 
solutions with styrene were freshly prepared for each trial.  
 
Figure 2.7. A plot of styrene concentration versus absorbance at 262 nm (average of 3 
trials). Error bars represent standard deviation. 
2.3 Results and discussion 
2.3.1 The proton NMR study 
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        The chemical shifts of two beta protons of Cys 29 in the WT were observed at +39.5 
ppm and -21.5 ppm, which are consistent with results reported by Wang et al. (183). The 
signal of His Hε of HRP is located at -31.0 ppm, consistent with results reported previously 
(223). The chemical shifts at +60.0 ppm and -28.5 ppm were assigned to His 29 Hδ and Hε 
of the mutant enzyme, respectively. The difference in the location of Hδ signals in HRP 
and C29H might be attributed to the differences in the orientation of the proximal His with 
respect to the heme. Thus, the substitution of the proximal Cys in C29H CPO was 
confirmed by 1H-NMR spectroscopy.  
 
Figure 2.8. 600-MHz proton NMR spectra of cyanide complexes of HRP, WT and C29H 
CPO in deuterated phosphate buffer, pH 5.9. 
2.3.2 Circular dichroism of WT and variant CPO 
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        Circular dichroism spectroscopy was used to determine if substitution of Cys 29 with 
a His had a significant effect on the secondary structure of CPO, which in turn might affect 
the substrate affinity and enzymatic activity of the enzyme. Since the van der Waals volume 
of a histidine (118 A3) is larger than that of a cysteine (86 A3) (224, 225), it is likely that 
some perturbation of the mutant active site occurred which may affect the protein 
secondary structure, possibly in the proximal helix region where the proximal ligand is 
located. This, in turn, could affect the redox potential of the heme iron and biochemical 
properties of the protein. Thus, cysteine ligation might be important for maintaining a 
particular architecture of the active site necessary for catalytic diversity. 
        The secondary structures of the C29H and WT CPO were estimated using JASCO CD 
spectrometer and CDSSTR (Fig. 2.9). For WT, alpha-helical and beta-sheet contents were 
found to be 30% and 25%, respectively. For C29H, alpha-helices and beta-sheets were 
estimated at 34% and 20%, respectively. The differences in the secondary structural 
elements of the WT and the mutant are quite small and are unlikely to contribute 
significantly to the functional differences of these two enzymes. However, possible 
changes in the tertiary structure of the protein, especially proximal helix orientation (226), 
could affect the  redox potential and reactivity of C29H CPO.  
        Using CD spectroscopy, it is possible to determine if tertiary structural changes occur 
upon mutation; however, this method is not specific enough to indicate the region where 
the changes occur. In order to determine the locations and magnitude of the tertiary 
structural changes, it would be necessary to solve crystal structure of the mutant and 
compare it with that of the WT. 
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Figure 2.9. CD spectra of 1.0 µM WT and C29H CPO in acetate buffer, pH 5.5. 
2.3.3 UV-Visible spectroscopic properties of WT and C29H CPO 
        UV-Vis spectrophotometry was used to obtain a spectroscopic signature of CPO that 
can provide useful information about the electronic, magnetic, and molecular structure of 
the heme active center. The spectrum of WT CPO shows the Soret peak at 398 nm as well 
as β, α, and charge transfer (CT) bands at 515, 545, and 650 nm, respectively (Fig. 2.10 
and Table 2.5). The peaks at 515 and 650 nm are considered the high-spin markers 
indicating that ferric WT CPO is in high-spin pentacoordinate form. The Soret band of 
C29H is red shifted to 419 nm. The Q bands shifted as well to 540 and 570 nm indicating 
that ferric C29H possesses low-spin heme that is coordinated to a sixth ligand, possibly 
water or an amino acid in the distal active site. Furthermore, it has been proposed that the 
relative intensities of the α and β bands can be an indication of how close in energy the a2u 
and a1u orbitals of porphyrin are (179, Figs. 1.20 and 1.21). 
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Figure 2.10. UV-Vis spectra of WT and C29H CPO in 25 mM phosphate buffer, pH 5.9. 
 
Table 2.5. UV-Vis spectral properties of ferric WT and C29H CPO in phosphate buffer, 
pH 5.9 (n.s.-no shoulder, s.s.-slight shoulder, l.i.-low intensity). 
 
Protein δ band  
(nm) 
Soret 
 (nm) 
β band 
 (nm) 
α band  
(nm) 
CT 
 (nm) 
WT CPO -- 398 (n.s.) 515 550 650 
C29H 354 419 (s.s.) 540 570 645 (l.i.) 
 
If the two orbitals are very similar in energy, the α/β intensity ratio will be small. The α/β 
intensity ratios of WT and C29H CPO suggest that a2u and a1u porphyrin orbitals in WT 
are closer in energy than those in C29H mutant. In addition, the spectrum of C29H exhibits 
a clear δ-band, which indicates that the heme iron is in a low spin. Moreover, the δ-band 
was proposed to be a result of an electron cloud density around the heme, and hence can 
be viewed as a sensor for the heme redox state (227). 
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        To investigate the pH influence on the structure of CPO, the absorption spectra of 
both WT and C29H CPO in a phosphate buffer at different pH were obtained. It is well 
known that WT CPO transforms from the active high-spin state to the inactive low-spin 
form at alkaline pH (228). The pKa for the transition of the active WT CPO to the inactive 
C420 form was determined to be 7.5 by Blanke et al. (228). It has been proposed that at 
this pH, deprotonation of an amino acid in the active site results in further ionization of 
other residues, which in turn induces a conformational change in the protein.  Later, it has 
been shown that this ionizable amino acid interacts with the heme iron. It is possible that 
these interactions prevent ligand binding to the alkaline form since exogenous molecules 
were shown to be unable to bind heme (228). Therefore, the inactivation of CPO might be 
a result of its inability to bind H2O2, which is required for formation of the catalytic 
species, Cpd I. 
        Wild-type CPO at neutral and acidic pH exists as a pentacoordinate high-spin form as 
suggested by its UV-Visible spectrum (Fig. 2.11). At pH 8.0 and above, the heme iron state 
changes to a low-spin as evident from the red shift of the Soret band and decrease in 
absorbance at 515 and 650 nm (high spin markers). My results are consistent with 
previously reported data and show that transition to the alkaline low-spin, hexacoordinate 
form occurs between pH 7 and 8 (Fig. 2.11).  
        Different results are observed for C29H, which stays in a hexacoordinate, low-spin 
state over a wide range of pH from very acidic to alkaline (Figs. 2.12 and 2.13). The 
spectrum starts changing at pH 3.5. The intensity of the Soret band starts decreasing and a 
new peak at around 400 nm is observed at pH 2.5 indicating transitioning from the low 
spin species to the high spin form.  
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Figure 2.11. UV-Vis absorption spectra of WT CPO in phosphate or phosphate-citrate 
buffer at different pH. 
 
Figure 2.12. UV-Vis absorption spectra of C29H CPO in phosphate or phosphate-citrate 
buffer in the acidic pH range. 
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Figure 2.13. UV-Vis absorption spectra of C29H CPO in phosphate-citrate buffer in basic 
pH. 
 
        These spectroscopic results also suggest that the distal ligand, possibly water or an 
amino acid, is very acidic with a low pKa. Even though it would be unusual for water to 
have such a low pKa (below 3.5), it is possible that its interactions with heme result in a 
pKa decrease.  
2.3.4 CO binding to WT, C29H CPO, C29H/C79H, and C29H/C79H/C87H CPO 
        Binding of ligands to CPO depends on the size of the ligands and their pKa values. 
Quite a few ligands were found to bind either to ferric or ferrous CPO. The ligands include 
but are not limited to dioxygen, carbon monoxide, cyanide, pyridine, nitrate, nitrite, 
thiocyanate, imidazole, organic isocyanides, and acetate (174, 219). In general, the binding 
properties of CPO are similar to those of classical peroxidases. An exception is the binding 
of carbon monoxide to ferrous CPO to produce an absorption peak at around 450 nm, 
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similar to cytochromes P450. It has been postulated that thiolate ligation in P450s and CPO 
enzymes is responsible for the observed unique 450-nm absorption. (9). Several studies 
utilized heme Soret band absorption location for a ferrous protein-CO complex to 
investigate the nature of the proximal ligand, stating that cysteine and histidine, upon 
binding CO, would produce the peak near 450 nm and 420 nm, respectively (106, 196, 
211-215). 
        My results with C29H CPO mutant shown in Figure 2.14 indicate that proximal 
cysteine is not a prerequisite for the P450-like spectroscopic signature. The Soret band of 
C29H upon reduction with sodium dithionite shifts from 419 nm to 407 nm. The spectrum 
of C29H-CO complex (444 nm) is almost identical to that of the WT-CO (445 nm) although 
the two enzymes have dramatically different proximal ligation (Fig. 2.15). 
 
 
 
Figure 2.14. UV-Vis absorption spectra of ferric C29H, ferrous C29H, and ferrous C29H-
CO complex in phosphate buffer, pH 5.9. 
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Figure 2.15. UV-Vis absorption spectra of ferrous WT-CO and C29H-CO at pH 5.9. 
 
        It can be argued that the absorption peak near 450 nm might be the result of the switch 
of a His to a Cys ligation since CPO possesses two more cysteines (Fig 2.16). However, 
even though such a switch is possible, it is unlikely because of the location of both Cys 
residues in the helix C and their involvement in the formation of a disulfide bond. Swapping 
of a proximal His in C29H CPO would require significant changes in the tertiary structure 
of the protein and is very unlikely to occur.  
        To further investigate the possibility of the His to Cys switch, Cys 79 and Cys 87 were 
also replaced with a His to create double and triple CPO mutants, C29H/C79H and 
C29H/C79H/C87H. The spectra of mutant-CO complexes are shown in Figure 2.17. Both 
mutant-CO absorb at 444 nm, similarly to the WT-CO. Since C29H/C79H/C87H mutant 
is devoid of Cys, it cannot form a thiolate ligation. This finding supports my hypothesis 
that thiolate is not a prerequisite for the P450-like spectroscopic signature of CPO. 
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Figure 2.16. Locations of 3 cysteine residues in CPO. The following pdb file was used to 
visualize CPO: 1CPO (75). 
 
 
Figure 2.17. UV-Vis absorption spectra of ferrous C29H/C79H-CO and 
C29H/C79H/C87H-CO at pH 5.9. 
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2.3.5 CN- binding to WT and C29H CPO 
        Cyanide is a known inhibitor of CPO and binds to other heme proteins as well. The 
spectra of the WT CPO and its cyanide complex were obtained at pH 5.9. Since cyanide is 
a very weak acid with a pKa of 9.14 (229), it binds to the ferric state of CPO in its 
protonated form at pH 5.9. Upon binding cyanide, the spin state of CPO changes from high 
to low as evident from the Soret band shift from 398 nm to 439 nm, the presence of the δ-
band, and the disappearance of the CT band at 650 nm (Fig. 2.18, Table 2.6). After 15-min 
incubation, the spectrum of the WT-CN complex remained the same.  
        The change in the spin state of iron occurs because of the rearrangement of electrons 
in the molecular orbital of heme. According to the ligand-field theory originally developed 
by Bethe (230) and later extended by others (231, 232), ligand electrons interact with 
electrons in d orbitals of the iron (Fig. 1.21) resulting in a particular energy gap between 
the d(xy), d(xz), d(yz) and d(x2-y2), d(z2) orbitals called the crystal-field splitting energy. 
If this energy difference is larger than the electron pairing energy, then electrons fill up the 
lower energy orbitals (dxy, dxz, dyz) first resulting in a low spin state. If the crystal-field 
splitting energy is smaller than the electron pairing energy, then electrons fill up empty dx2-
y2 and dz2 orbitals before pairing in dxy, dxz, and dyz orbitals, resulting in a high spin state. 
Since cyanide is a strong field ligand, its binding to iron leads to a high crystal-field 
splitting energy in d orbitals resulting in a low spin heme. 
        Slightly different behavior is observed for the C29H-CN complex, the Soret peak of 
which shifts with time from 436 nm to 424 nm, in contrast to the unchanged WT-CN Soret 
absorption (Fig. 2.19). This indicates that cyanide competes with another axial ligand, 
possibly water, and has a lower affinity for the mutant than for the WT. 
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Figure 2.18. UV-Vis spectra of ferric WT and WT-CN in phosphate buffer, pH 5.9. 
 
 
Figure 2.19. UV-Vis spectra of ferric C29H and C29H-CN in phosphate buffer, pH 5.9. 
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Table 2.6. UV-Vis spectral properties of ferric WT and C29H CPO and their cyanide 
complexes at pH 5.9. 
Protein δ band 
(nm) 
Soret 
 (nm) 
β band 
(nm) 
α band 
(nm) 
CT 
(nm) 
WT CPO  -- 398 515 550 650 
WT-CN  364 439 -- 564 -- 
C29H CPO  354 419 540 570 645 
C29H-CN  364 436→424 -- 558 -- 
 
2.3.6 Catalytic properties of WT and C29H CPO  
        To investigate the effect of proximal ligand substitution on the catalytic capabilities 
of CPO, the activities of C29H and WT were measured in 4 different assays: chlorination 
of MCD, dismutation of H2O2, epoxidation of styrene, and peroxidation of ABTS (Figs. 
2.20-2.23). C29H CPO showed a 10-fold and more than 50-fold increase in epoxidation 
(pH 4.5) and peroxidation (pH 4.5) rates, respectively, while essentially abolishing 
dismutation (pH 4.5) activity.  In addition, the chlorination (pH 2.75) activity of the mutant 
was only about 0.5% of the original activity of CPO (Fig. 2.24). 
        Catalysis of heme proteins is generally influenced by such factors as heme iron redox 
potential, bond length between iron and proximal ligand, active site polarity, and 
accessibility of the heme to substrates. Inability of C29H to carry out chlorination and 
dismutation reactions could be caused by the change in the redox potential of iron (233). 
        Since thiolate ligation provides a stronger push than less electronegative imidazole, 
the substitution of Cys with a His is expected to increase the redox potential of the heme 
iron (234). However, a mere substitution of a proximal ligand for a less electronegative 
residue does not necessarily result in redox potential increase since multiple factors 
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determine activity. For example, C357H P450cam loses its oxygenase activity upon 
substitution of Cys 357 with a His (208, 209) while the activity of myoglobin is increased 
when proximal His is replaced with a Cys (196, 196).  
 
Figure 2.20. Chlorination of MCD to DCD by WT and C29H CPO at pH 2.75. 
 
Figure 2.21. Dismutation of H2O2 by WT and C29H CPO at pH 4.5. 
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Figure 2.22. Epoxidation of styrene by WT and C29H CPO at pH 4.5. 
 
Figure 2.23. ABTS peroxidation by WT and C29H CPO at pH 4.5. 
        My results on C29H catalysis suggest a decrease in the redox potential of the mutant, 
which in turn would lead to changes in the distal axial ligand pKa, important for the 
formation of the active catalytic intermediates (Cpd I, Cpd II, Cpd X) (109, 204). Redox 
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potential and basicity of the distal ligand have an inverse relationship (235, 236), so 
increase in the ligand basicity would be expected. A more basic distal ligand is easier to 
protonate, which partly explains the increase in peroxidation activity, which requires Cpd 
II formation. It is possible that WT-Cpd II is harder to protonate at pH 4.5, resulting in 
lower activity than in the mutant, whose Cpd II pKa is higher. Similarly, lack of 
dismutation activity can be explained by changes in a substrate pKa that might prevent 
binding of hydrogen peroxide to Cpd I.  
 
 
 
Figure 2.24. Relative activities of WT (RZ=1.3-1.5) and C29H CPO (RZ=1.2-1.5) in 
chlorination (pH 2.75), epoxidation (pH 4.5), dismutation (pH 4.5), and peroxidation (pH 
4.5) assays. 
 
       The lack of dismutation activity in the mutant is expected to contribute to the increase 
in peroxidation and epoxidation rates, since there is no depletion of Cpd I and oxidizing 
agent (peroxide) via the dismutation pathway. Another possible contribution to the increase 
in epoxidation activity is better heme center accessibility by substrate, which is important 
for two-electron oxidations by heme enzymes (237). The astounding increase in ABTS 
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oxidation rates could be a result of perturbations in the active site affecting the heme-edge 
accessibility required for one-electron oxidations (29). Similar observations were made in 
cytochrome P450 by Auclair et al., where the Cys 357→His mutation resulted in a novel 
peroxidase activity of the enzyme (30). My results indicate that thiolate ligation is required 
for dismutation and chlorination activities of CPO, but is not important for peroxidation 
and epoxidation reactions. 
2.3.7 pH profiles of catalytic activities of WT and C29H CPO 
        Catalytic properties of CPO are highly pH dependent. To investigate how pH affects 
reaction rates of both WT and C29H CPO, four assays discussed above were performed at 
various pH. No significant chlorination or dismutation activities were observed for C29H 
at any pH checked (Figs. 2.25 and 2.26). As discussed in the previous section, C29H may 
be unable to form the protonated Cpd X and Cpd I-peroxide species required for 
chlorination and dismutation reactions, respectively. 
        Interestingly, C29H maintained both epoxidase and peroxidase activities over a much 
wider pH range than the WT (Figs. 2.27 and 2.28). The rates of the epoxidation reaction 
catalyzed by WT CPO do not fluctuate significantly over the entire active pH range, 
suggesting little influence of pH on the epoxidation activity of the WT. However, a clear 
optimum of pH 4.5 is observed for C29H CPO. Such a pH profile is consistent with the 
fact that abolishing dismutation activity should contribute to the increase in epoxidation, 
and since the highest dismutation activity of the WT is at pH 4.5, the largest increase is 
observed at that particular pH. Alternatively, epoxidation reactions catalyzed by WT and 
C29H CPO might proceed via a dual pathway involving different active intermediates, as 
has been suggested for the epoxidations catalyzed by CYPs (149). 
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Figure 2.25. pH profile of chlorination activities of WT and C29H CPO (some error bars 
are smaller than point size and are not visible on the graph). 
 
 
Figure 2.26. pH profile of dismutation activities of WT and C29H CPO (some error bars 
are smaller than point size and are not visible on the graph). 
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Figure 2.27. pH profile of epoxidation activities of WT and C29H CPO (some error bars 
are smaller than point size and are not visible on the graph). 
 
        In the peroxidation assay, the WT CPO reaction rates are significantly reduced above 
pH 3.5 while the mutant remains active even at pH 5.5. Since Cpd I is the active species in 
the catalytic cycle of CPO, C29H must be able to form this intermediate at both acidic and 
neutral pH in contrast to the WT, which loses activity at neutral pH because of the 
formation of the inactive alkaline form (228). C29H-Cpd I formation at higher pH can be 
explained by the fact that the mutant does not undergo alkaline transition near neutral pH 
as observed in the WT. In addition, if Cpd II, the second intermediate in the peroxidation 
pathway, is indeed an iron(IV)-hydroxide intermediate as suggested by Green and Lai 
(107), then its pKa would affect the optimal pH. WT is active in the peroxidation assay at 
very acidic pH, suggesting that the pKa of WT-Cpd II is below 3.25. In C29H, the pKa of 
Cpd II might be significantly higher (around 4-4.5), and that would result in the formation 
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of the active protonated Cpd II at higher pH. For this reason, it is understandable that C29H 
CPO is able to carry out peroxidation over a wider pH range than the WT.  
 
Figure 2.28. pH profile of peroxidation activities of WT and C29H CPO (some error bars 
are smaller than point size and are not visible on the graph). 
 
        Overall, this study suggests that thiolate ligation plays an important role in both the 
structure and catalysis of CPO, and substitution with a histidine affects the biochemical 
properties of the enzyme not only because of the different natures of the ligands but also 
because of possible changes in the protein architecture. Although, secondary structures of 
the WT and C29H did not differ significantly as measured by CD, it is possible that tertiary 
changes have affected the heme environment (for example, the high to low spin conversion 
and the change in the heme coordination), which is important for the enzyme function. 
Furthermore, my results on CO binding to single, double, and triple Cys mutants have 
shown that proximal thiolate ligation is not required for P450-type spectroscopic properties 
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of CPO. However, proximal thiolate is important for binding of anionic ligands. 
2.4 Conclusion 
       After years of research on heme catalysis, there is still an ongoing debate about the 
importance of the proximal thiolate ligation in heme proteins. Several proximal ligand 
mutant heme proteins were engineered and characterized by different researchers with 
varying success, and no consensus on the role of proximal Cys has been achieved. In this 
study, I employed rational design to investigate the role of Cys 29 in biochemical and 
physical properties of CPO. Three CPO mutants (C29H, C29H/C79H, C29H/C79H/C87H) 
with proximal imidazole ligation were constructed using site-directed mutagenesis and 
characterized using various spectroscopic techniques. My study has demonstrated that 
proximal thiolate ligation is important for the catalytic diversity of CPO, particularly for 
chlorination and dismutation activities. However, it is not essential for peroxidation and 
epoxidation. Furthermore, I discovered that thiolate ligation is not a prerequisite for the 
P450-like spectroscopic signature of CPO. This finding is quite unexpected since it has 
been proposed that proximal Cys ligation in CYPs and CPO is responsible for the unique 
optical property of these proteins. My work has provided solid support for the importance 
of thiolate ligation in heme catalysis and has opened new avenues for further exploration 
of factors defining biochemical properties of heme enzymes. 
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CHAPTER III. 
EFFECTS OF HYDROGEN BOND NETWORK IN THE PROXIMAL HELIX ON 
THE SPECTROSCOPIC PROPERTIES OF CHLOROPEROXIDASE 
3.1 Background 
        Despite extensive research performed on various heme-thiolate enzymes including 
CYPs, CPO, and NO synthase, much remains to be explored about mechanisms influencing 
their catalysis (28, 31-33). Various spectroscopic techniques along with site-directed 
mutagenesis are utilized to obtain information about how particular protein structural 
features influence its function. It has been shown that the nature of the proximal and distal 
ligands as well as hydrogen bonding networks in the active site play important roles in 
defining the biochemical and physical properties of heme proteins. In general, the redox 
potentials of heme proteins decrease with more electronegative proximal ligands creating 
the following trend: imidazole > thiolate > phenolate (48). However, proximal imidazole 
ligation does not guarantee higher redox potential since the overall architecture of the 
active site fine-tunes reactivity. For example, the redox potentials of CPO, a heme thiolate 
protein, and HRP, a heme imidazolate enzyme, are -140 mV and -278 mV at pH 7, 
respectively (48), which implicates the critical role of hydrogen bonding networks within 
the active site in determining the structural and functional properties of heme proteins. 
        In the proximal site of CPO, there are 2 H-bonds between Cys 29 and the amide groups 
of Ala 31 and Leu 32 situated at the N-terminus of helix A (98). These H-bonds prevent 
protonation of the thiolate, which results in inactivation of CPO, and decrease its negative 
charge thus contributing to the increase of the iron redox potential (101, 102). In addition 
to these H-bonds, there is another H-bonding network formed by Arg 26-Asn 37 and Ala 
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27-Asn 33, which is a part of helix A of CPO (Fig. 3.1). The effects of this H-bonding 
network on the spectroscopic and catalytic properties of CPO are unknown. 
 
Figure 3.1. Hydrogen bond network in the proximal helix of CPO. 
        In this study, I explored how the partial or complete removal of the aforementioned 
H-bonds affected spectroscopic properties of CPO. I replaced Arg 26 and Asn 33 with Ala 
to disrupt H-bonding and characterized R26A, N33A, and R26A/N33A CPO using UV-
Vis spectrophotometry and CD spectroscopy.  
        Electronic absorption spectroscopy, or UV-Vis spectrophotometry, is often used to 
probe the heme environment and its electronic structure, i. e., the coordination and spin 
state of the heme iron. As described in the introduction, a typical heme protein absorption 
spectrum (Fig. 18) (177) displays the Soret, δ, and Q (α, β, CT) bands that result from 
electronic transitions in the porphyrin (Fig. 19) (178). Shifts and shapes of these bands can 
provide information about the spin and coordination state of the heme iron. The Soret and 
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Q bands at lower wavelengths as well as a charge transfer band at around 650 nm indicate 
that the heme iron is in a high spin state. Furthermore, the intensities of the α and β bands 
relative to each other can provide information about relative energies of the a2u and a1u 
orbitals of the porphyrin. For example, if both orbitals are very similar in energy, the α/β 
intensity ratio will be small. On the contrary, if the a2u and a1u orbitals have different 
energies, the α/β intensity ratio will be large (179). 
        Other interactions that can be observed with UV-Vis spectrophotometry include 
porphyrin-iron and iron-ligand interactions. For example, ferrous iron has filled d π orbitals 
(d6), and electrons in d π (d(xz), d(yz)) orbitals of the iron strongly interact with electrons 
in porphyrin π* (a1u) orbital. Such strong interactions result in a larger separation between 
porphyrin π and π* (a2u and a1u) orbitals causing the hypsochromic (blue) shifts in 
electronic spectra (Fig. 20). In contrast, in metalloporphyrins with closed d-shells (d0 or 
d10), the d π metal orbitals have little effect on the π to π* energy separation in porphyrin 
electronic spectra because of their low energy (180). Ligand-binding studies can provide 
useful information about the environment of the active site and insights about catalytic 
mechanisms. Frequently, binding of a ligand in the heme distal side causes changes of the 
iron spin state. For example, CPO, whose resting state is a five-coordinate high spin form, 
changes to the low spin upon binding cyanide.  
        Circular dichroism is often used to investigate protein secondary and tertiary 
structures and to monitor structural changes in mutant proteins or protein-ligand 
complexes. Several algorithms are available for estimation of alpha-helical, beta-sheet, and 
random coil contents and include CONTINLL (184, 185), SELCON3 (186, 187), CDSSTR 
(188-190), VARSLC (188, 189), and K2D (191). One method might be more suitable than 
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others for the analysis of a particular protein since the aforementioned algorithms utilize 
different protein reference sets. For example, when analyzing globins, it is prudent to 
choose a program that has more globular proteins in its reference set so that better 
prediction of the protein structure can be made. In the case of CPO, I found that CDSSTR 
program produced more accurate estimations of secondary structures, especially for alpha-
helices that were in a better agreement with the published crystal structure of CPO. 
        Circular dichroism can provide useful information about integrity of protein domains 
expressed separately, protein stability under changing conditions, and structural alterations 
in mutants or upon ligand binding. For heme proteins, CD may also reflect changes in the 
environment of the heme (192). For example, heme absorbs strongly at around 410 nm and 
has additional signals between 500 and 600 nm. Thus, changes in those regions would 
indicate changes in the heme active site (238). 
       In this study, I utilized the techniques described above to probe the roles of proximal 
H-bonds in CPO. My results have shown that the H-bond network of the proximal helix is 
important not only for maintaining a local active site environment but also for the overall 
organization of CPO that in turn affects ligand binding. 
3.2 Experimental procedures 
        All chemicals and materials used are the same as described in section 2.2.1. 
3.2.1 Construction of R26A, N33A, and R26A/N33A CPO genes  
        To investigate the structural and spectroscopic roles of the hydrogen bond network in 
the proximal helix of CPO (Arg 26-Asn 37 and Ala 27-Asn 33), two single (R26A, N33A) 
mutants and one double (R26A/N33A) mutant were created. Mutations were introduced 
into the pCPO3.I – AmdS (Fig. 2.1) via PCR amplification using the QuikChange II XL 
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site-directed mutagenesis kit. Polymerase chain reaction was carried out as described in 
section 2.2.2. The following primers were used to introduce the R26A, N33A, and 
R26A/N33A mutations: 
Coding strain – R26A primer 1 
5’- CTACCGACTCTGCTGCTCCTTGCCCAGCTCTGAACG - 3’ 
Non-coding strain – R26A primer 2 
5’- GAGCTGGGCAAGGAGCAGCAGAGTCGGTAGGACCTG - 3’ 
Coding strain – N33A primer 1 
5’- CTTGCCCAGCTCTGGCCGCTCTTGCCAACCACGGTT - 3’ 
Non-coding strain – N33A primer 2 
5’- GTTGGCAAGAGCGGCCAGAGCTGGGCAAGGAGCACGAG - 3’ 
Coding strain – R26A/N33A primer 1 
5’- GTCCTACCGACTCTGCTGCTCCTTGCCCAGCTCTGG-3’ 
Non-coding strain – R26A/N33A primer 2 
5’- CAAGGAGCAGCAGAGTCGGTAGGACCTGGGGCGAC -3’ 
Polymerase chain reaction products were amplified in DH5-α E. Coli. Mutations were 
confirmed by DNA sequencing (Figs. 3.2-3.4).  
 
Figure 3.2. R26A pCPO sequencing results. 
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Figure 3.3. N33A pCPO sequencing results. 
 
 
Figure 3.4. R26A/N33A pCPO sequencing results. 
3.2.2 Transformation of Aspergillus niger with mutant pCPO, expression and 
purification of R26A, N33A, and R26A/N33A CPO 
        Transformation of A. niger with mutant pCPO was performed as described in section 
2.2.3. Expression and purification of mutant CPO was carried out as described in section 
2.2.4 with some modifications. Expression of R26A CPO proved to be quite difficult. Since 
R26A had low expression levels, 72 L of culture were grown. After purification, the protein 
contained both halo- and apoprotein. Hoping to improve incorporation of heme into the 
R26A mutant, I added hemin to cultures grown at 25°C for three days to a final 
concentration of either 25 µM or 50µM. 
        During purification on DEAE column, R26A CPO eluted at approximately 20% 0.5 
M NaCl. Fractions with RZ values (A420/A280) above 0.5 were used for further purification 
by size exclusion chromatography (Fig. 3.5). Fractions with RZ values between 1.0 – 1.1 
were used in subsequent studies. Purity of the mutant CPO was assessed by SDS-PAGE 
(Figs. 3.6 and 3.7). 
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Figure 3.5. R26A CPO sample loaded on a gel filtration column. 
 
Figure 3.6. SDS-PAGE. WT and R26A CPO. Lanes 1 and 2 – R26A, lane 3 – WT CPO. 
        Expression of the other two mutants, N33A and R26A/N33A, produced better yields, 
thus 36-L and 30-L cultures were grown, respectively. During ion-exchange 
chromatography, N33A and R26A/N33A CPO eluted at approximately 30% and 20% 0.5 
M NaCl, respectively. Fractions with RZ values (A420/A280) above 0.6 and 0.5, 
respectively, were used for further purification by size exclusion chromatography. 
Fractions with RZ values between 1.0 – 1.1 were used in subsequent studies. Purity of the 
mutant CPO was assessed by SDS-PAGE. 
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Figure 3.7. SDS-PAGE. N33A CPO. WT – wild type CPO, 2-6 – N33A fractions from gel 
filtration, M – marker.  
 
3.2.3 UV-Visible spectrophotometry  
        UV-Visible spectrophotometry was used to investigate heme electronic configuration 
and ligand-binding properties of the mutants lacking hydrogen bonds in the proximal helix 
A of CPO. The procedures are described in sections 2.2.5.3 and 2.2.6 with the following 
modifications. The effect of pH study was performed at pH 2.4, 3.5, 6.0, 8.0, 10.0. Excess 
cyanide (100 mM) binding was performed at pH 6.0 and pH 12.0. Titrations of CPO (10-
800 μM for WT and 1-10 mM for mutants) with CN- were performed in a phosphate buffer, 
pH 6.0. The cyanide dissociation constant (Kd), which is an inverse of a binding constant 
(K), was calculated from the following equation (239): 
1
∆𝐴𝐴
= 1[𝑆𝑆] × 1𝐾𝐾∆𝐴𝐴∞ + 1∆𝐴𝐴∞        ,                   (3.1) 
where ∆𝑆𝑆 is the maximum absorbance difference, ∆𝑆𝑆∞ is the change in absorbance of 
CPO-CN complete formation, K is a binding affinity constant, and [S] is the concentration 
of free CN-. The Hill equation (240) was used to determine the stoichiometry of CN- 
binding to mutants. In Eq. 3.2, h is the number of binding sites: log � ∆𝐴𝐴
∆𝐴𝐴∞−∆𝐴𝐴
� = ℎ × log[𝑆𝑆] + log (𝐾𝐾)                                  (3.2) 
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3.2.4 CD spectroscopy  
        Circular dichroism spectroscopy was used to probe possible changes in secondary and 
tertiary structures of mutant CPOs as a result of the proximal helix hydrogen bond network 
disruption. Procedures for the secondary CD are described in section 2.2.5.2. As for the 
tertiary CD, the spectra of 16 µM R26A, 35 µM N33A, 11 µM R26A/N33A, and 
corresponding concentrations of WT CPO in phosphate buffer, pH 5.9 were collected in 
the 250-600 nm range at room temperature using 1-cm quartz cuvettes. Three spectra were 
averaged for each protein. 
3.3 Results and discussion 
3.3.1 Secondary and tertiary CD spectroscopy of WT and mutant CPO 
        Asn 33 and Asn 37 are hydrogen bonded to Ala 27 and Arg 26, respectively, and are 
located in proximal helix A. Helix A also contains Cys 29 coordinated to the heme, thus 
deletion of the H-bonds in either of the aforementioned residue pairs might affect both the 
local environment of the heme and the alpha-helical structure of CPO. Structural 
alterations, in turn, could influence catalytic and binding properties of CPO. Removal of 
all H-bonds in the proximal helix is expected to have a larger effect on the helix A position, 
possibly influencing its flexibility, which also might affect the proximal site environment.  
        The secondary CD spectra of the single amino acid mutants, R26A and N33A, show 
only slight changes while the CD spectrum of R26A/N33A is significantly different from 
that of the WT (Fig. 3.8). As estimated by CDSSTR, the alpha helical structures of WT, 
R26A, N33A, and R26A/N33A are 31%, 29%, 30%, and 51%, respectively. The beta-
sheets have been estimated to be at 25%, 23%, 22%, and 18%, respectively. Disruption of 
the pair of hydrogen bonds between either R26-N37 or A27-N33 does not seem to 
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significantly change secondary structure of CPO. However, removal of both pairs of H-
bonds results in a noticeable alteration of the alpha-helix (20%-increase). Since the amino 
acids directly adjacent to the proximal helix are disordered, it is possible that the absence 
of the H-bonds promotes organization of this region into an alpha helix extending helix A 
affecting its rigidity. Such changes in the proximal helix would affect the local heme 
environment since Cys 29, the heme ligand, is situated in this helix.        
 
 
Figure 3.8. Secondary CD of 1.0 µM WT and mutant CPO in phosphate buffer, pH 5.9. 
 
        To investigate whether mutations in the active site of CPO affect its tertiary structure, 
CD spectra of the WT and the mutants have been taken in the 250-600 nm region (Figs. 
11-13). All mutants exhibit significant tertiary spectral changes in both aromatic and heme 
regions. Aromatic residues (Phe, Trp, Tyr) as well as disulfide bonds produce signals 
between 250 and 330 nm. Trp, Tyr, and Phe absorb at around 290 nm, 280 nm, and 260-
270 nm, respectively (241). In addition, the disulfide bond band extends from about 330 
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nm to its maximum at around 260 nm and is usually weak. However, its intensity depends 
on C-S-S bond angle, dihedral angle of the disulfide bond, and effects of surrounding 
groups (238). Chloroperoxidase has 18 Phe, 5 Trp, and 11 Tyr in its primary structure. 
Thus the broad positive signal in 275-300 nm region is likely produced by Trp and Tyr 
residues. The negative band at around 265 nm can be a combination of absorptions arising 
from Phe and a disulfide bond between Cys 79 and Cys 87. All three mutants produce 
negative signals in aromatic region, which indicate changes in the rigidity or environment 
of aromatic residues and possibly of the disulfide bond region. 
        The region between 400 – 650 nm provides information about the heme environment. 
Heme absorbs at around 350 nm (delta band), 410 nm (Soret), and between 500-650 nm 
(Q bands). In the CD spectrum of WT CPO, the heme group has strong absorptions at 428 
nm (Soret) and 545 (Q band) nm. Additional weak negative signals are located at 372 nm 
and 480 nm. Spectra of the mutants are markedly different from that of the WT (Figs. 3.9-
3.11 and Table 3.1). The signals described above for the WT disappear in R26A with the 
exception of a weak absorption at around 480 nm. There is a broad negative peak in 500-
600 nm region with two maxima at 561 nm and 572 nm. The CD spectrum of R26A 
suggests that the heme environment in R26A is quite different from that in the WT. In 
addition, the absence of the Soret signal may reflect poor incorporation of the heme into 
the R26A mutant, which is also supported by the lower RZ value. Furthermore, the Soret 
band in R26A UV-Vis spectrum decreases significantly within 1-2 months of protein 
expression, indicating low mutant stability. A very weak signal at around 344-350 nm 
(delta band) is present in the spectra of all three mutants, which indicates that the 
electronegative environment of the heme has changed in H-bond deletion mutants.  
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Figure 3.9. Tertiary CD spectra of 16 µM WT and R26A CPO at pH 5.9. 
 
 
Figure 3.10. Tertiary CD spectra of 35 µM WT and N33A CPO at pH 5.9. 
In N33A and R26A/N33A, the Soret bands are observed at 424 nm and 420 nm, 
respectively, and are broader than that of the WT with a shoulder at around 400 nm.  
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Figure 3.11 Tertiary CD spectra of 11 µM WT and R26A-N33A CPO in phosphate buffer, 
pH 5.9. 
Table 3.1. CD spectral properties of ferric WT and mutant CPO in phosphate buffer, pH 
5.9 in the heme region ((+), (-), (s) indicate positive and negative signals, and a shoulder 
in a band, respectively).  
Protein δ band (nm) Soret (nm) CT band 
(nm) 
Q bands (nm) 
WT CPO  372(-) 428(--) 480(-) 545(++) 
R26A CPO 344(-) -- 481(-) 561(--), 572(--) 
N33A CPO 350(-) 424(--) (s) -- 547(+), 559(-), 579(-) 
R26A/N33A 
CPO 
345(-) 420(--) (s) -- 575(--), 580(--) 
In the spectra of both N33A and R26A/N33A mutants, there are no signals at 370 nm and 
480 nm; however, three and two Q bands are present, respectively. These observations 
suggest that the heme active centers in those two mutants are similar to each other but 
different from that in the WT. 
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        Overall, the CD results indicate that the largest secondary structural changes have 
occurred in the R26A/N33A affecting alpha-helical content, while the heme environment 
has been altered in all three mutants. To further investigate the properties of the heme, UV-
Vis spectroscopy was employed, and the results are discussed in the following section. 
3.3.2 UV-Vis spectroscopic properties of WT, R26A, N33A, and R26A/N33A CPO 
        As mentioned before, heme proteins possess a spectroscopic signature in the UV-
Visible region that can provide useful information about the electronic and molecular 
structure of the heme active site. The spectrum of WT CPO shows the Soret band at 398 
nm as well as β, α, and CT signals at 515, 545, and 650 nm, respectively (Figs. 14, 15). 
The β and α bands are not well-resolved indicating greater mixing of the a2u and a1u 
porphyrin orbitals. The high spin markers at 515 and 650 nm indicate that the heme iron is 
in the high-spin pentacoordinate form. The Soret and Q bands of the mutants are red-shifted 
and their positions are consistent with mutants having a low spin heme (Fig. 3.12 and Table 
3.2). 
Table 3.2. UV-Vis spectral properties of ferric WT and mutant CPO at pH 5.9 (s-shoulder, 
n.s.- no shoulder, s.s.- slight shoulder). 
Protein δ band  
(nm) 
Soret  
(nm) 
β band 
(nm) 
α band 
(nm) 
CT 
(nm) 
WT CPO  -- 398 (n.s.) 515 550 650 
R26A CPO 354 418 (s) 540 568 644 (low) 
N33A CPO 356 420 (n.s.) 540 575 -- 
R26A/N33A CPO 356 421 (s.s.) 540 575 644 (low) 
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Figure 3.12. UV-Vis spectra of WT, R26A, N33A, and R26A/N33A CPO in 25 mM 
phosphate buffer, pH 5.9. 
         The Q bands at around 540 nm and 570 nm in the mutant spectra indicate that ferric 
mutants possess the hexacoordinate low-spin heme with water or an amino acid as a distal 
ligand. R26A and R26A/N33A show very low absorption peaks at 644 nm, which suggests 
that a small fraction of the protein might be a high-spin state. Furthermore, the α/β band 
intensity ratio in WT spectrum is similar to that in R26A and lower than that in N33A and 
R26A/N33A mutant spectra (Fig. 15). These ratios suggest that a2u and a1u porphyrin 
orbitals (Figs. 1.20 and 1.21) in WT and R26A might be closer in energy than those in 
N33A and R26A/N33A. In addition, the spectra of all mutants possess a clear δ-band, 
which is also an indication of a low-spin heme. 
        To investigate structural changes in CPO at acidic and alkaline pH, the UV-Vis 
spectra of both WT and mutants were taken at 2.4-10.0 pH range. Wild-type CPO remains 
in a high spin penta-coordinate form in the acidic pH range, and converts from the active 
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high-spin state to the inactive low-spin form at pH above 7.5 (220). It has been suggested 
that at this pH, an amino acid in the active site of CPO is deprotonated, which results in 
further ionization of other residues.  The ionizable amino acid interacts with the heme iron, 
which influences its pKa. It was also shown that binding of exogenous ligands to the 
alkaline form of CPO is difficult or impossible (228). These observations indicate that 
interactions of the ionizable residue with the heme might prevent binding of H2O2 to heme 
required for Cpd I formation, thus resulting in inactivation of CPO. 
        My spectral results are consistent with those reported previously and show that WT 
CPO is stable even at very acidic pH (2.4) and its transition to the alkaline low-spin 
hexacoordinate form occurs between pH 7 and 8 (Fig. 2.11). Different UV-Vis spectra have 
been obtained for CPO H-bond mutants, which primarily exist in the low-spin 
hexacoordinate state in a broad pH range, except R26A (Figs. 3.13-3.17). The spectrum of 
N33A at pH 2.4 has a broad peak at around 380 nm without any Q bands present. Such a 
spectrum resembles that of free heme in aqueous solution, suggesting protein unfolding 
and exposure of heme to the solvent (242). Another transition occurs above pH 9.0 (Fig. 
3.14), which is likely because of the deprotonation of one or more critical residues with an 
apparent pKa near 10. It is also possible that partial denaturation of the protein occurs 
because of the high alkalinity. A similar transition is also observed for R26A/N33A at 
pH10.0 (Fig. 3.16). However, different results are obtained at acidic pH. The shape of the 
Soret band in R26A/N33A at pH 2.4 suggests that the transition from the low spin has not 
completely occurred and the double mutant has higher stability at pH 2.4 than N33A (Fig. 
3.15). A shoulder at around 400 nm emerging from the Soret band and a high-spin marker 
at around 650 nm indicate the mixed spin state of R26A/N33A. 
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Figure 3.13. UV-Vis absorption spectra of N33A CPO in the acidic pH range. 
 
Figure 3.14. UV-Vis absorption spectra of N33A CPO in basic pH. 
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Figure 3.15. UV-Vis absorption spectra of R26A/N33A CPO in the acidic pH range. 
 
Figure 3.16. UV-Vis absorption spectra of R26A/N33A CPO in basic pH. 
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Figure 3.17. UV-Vis absorption spectra of R26A CPO at various pH. 
        It should be noted that out of all CPO mutants created during my research, R26A had 
the lowest stability and it was the most difficult to express. Its decreased stability is evident 
from the spectral study with varying pH (fig. 3.17). The spectrum of R26A already starts 
changing at pH 5.0 in the acidic pH range, suggesting a conformational change involving 
protonation of a residue with a pKa around 5. Similar spectral changes occur at pH 8.0, 
indicating a second transition possibly involving deprotonation of another residue with a 
higher pKa.  
3.3.3 Ligand binding to WT and R26A, N33A, and R26A/N33A CPO 
        The ligand-binding properties of CPO mutants can be used to further probe their active 
site structures. Although WT CPO spectroscopic properties and heme iron coordination are 
similar to those in P450s, WT CPO possesses a peroxidase-like active site heme 
environment because its ligand-binding properties resemble those of classical peroxidases 
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(174). The size and pKa of exogenous ligands determine how they bind to CPO. Weakly 
acidic ligands bind in a protonated state and exhibit decreased affinities above their pKa 
(for example, cyanide, pKa 9.14). Strongly acidic ligands bind in a deprotonated form and 
exhibit larger variations in affinities especially at more acidic and alkaline pH (for example, 
thiocyanate, pKa -1.9). Affinities of neutral ligands do not depend on pH (for example, 
CO) (174). In this study, the binding of CO and CN- to the WT and mutant CPO was 
investigated. Since CO is a neutral ligand whose affinity does not depend on pH, its binding 
to the ferrous CPO was monitored at a single pH of 6.0. In contrast, weakly acidic CN- 
should exhibit lower affinity above pH 9.14 and, therefore, its binding to the ferric CPO 
was investigated at pH 6.0 and pH 12.0. 
3.3.3.1 CO binding to WT and mutant CPO 
        The Soret bands of the WT and mutant CPOs upon reduction with sodium dithionite 
shift to around 408 nm (Figs. 3.18-3.21 and Table 3.3).  
Table 3.3. Spectral properties of ferrous WT, R26A, N33A, and R26A/N33A CPO and 
their CO complexes. 
 
 
Protein δ band (nm) Soret (nm) Q band (nm) 
WT CPO -- 408 550 
WT-CO -- 445 550 
R26A -- 408  551 
R26A-CO -- 444 551 
N33A -- 407 551 
N33A-CO 358 443 551 
R26A/N33A -- 408  550 
R26A/N33A-CO 357 444 550 
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Figure 3.18. UV-Vis absorption spectra of ferric R26A, ferrous R26A, and ferrous 
R26A-CO complex in phosphate buffer, pH 5.9. 
 
 
 
Figure 3.19. UV-Vis absorption spectra of ferric N33A, ferrous N33A, and ferrous N33A-
CO complex in phosphate buffer, pH 5.9. 
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Figure 3.20. UV-Vis absorption spectra of ferric R26A/N33A, ferrous R26A/N33A, and 
ferrous R26A/N33A-CO complex in phosphate buffer, pH 5.9. 
 
Figure 3.21. Comparison of UV-Vis absorption spectra of ferrous mutant-CO complexes 
in phosphate buffer, pH 5.9. 
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The overall shape of WT, R26A, N33A, and R26A/N33A CPO spectra resemble each other 
suggesting similar ferrous CPO states in both the WT and mutants. The Soret absorption 
of the ferrous mutant CPO-CO complexes (443-444 nm) is almost identical to that of the 
ferrous WT-CO (445 nm) (Fig. 3.21). Interestingly, N33A-CO and R26A/N33A-CO 
complexes show the delta band at 358 nm and 357 nm, respectively, with the first mutant 
having more defined peak (Fig. 3.21). The presence of delta band indicates differences in 
the electronegative environment of the heme in these two mutants, which can influence the 
catalytic properties of CPO (discussed in chapter IV). 
3.3.3.2 Cyanide binding to WT and mutant CPO 
        To examine mutant ligand-binding properties further, the UV-Vis spectra of ferric 
WT and mutant cyanide complexes were obtained at pH 6.0 and pH 12.0 in the presence 
of CN- excess (100 mM). The spectra were recorded upon addition of cyanide (0 min) and 
after incubation of the sample for 1 hour at room temperature (60 min) (Figs. 3.22-3.25). 
First, I will discuss results obtained at acidic pH. The absorption spectra of the ferric WT-
CN and mutant-CN resemble each other, exhibiting delta, Soret, and alpha bands. The 
initial Soret position in the mutant-CN spectra is similar to that of the WT-CN (Table 3.4). 
However, after a 1-hour incubation, mutant Soret bands have shifted to slightly different 
locations with N33A-CN Soret blue-shifted the most (10 nm) while R26A and R26A/N33A 
Soret bands blue-shifted only 4 nm and 2 nm, respectively. The spectrum of the ferric WT-
CN remained the same after 1 hour, indicating stronger CN- binding to the WT.  To address 
the question of whether CN- affinity is higher for the WT CPO than for the mutants, both 
WT and mutant CPOs were titrated with potassium cyanide at pH 6.0 to determine cyanide 
dissociation constant. 
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Figure 3.22. Cyanide (100 mM) binding to WT CPO in phosphate buffer, pH 6.0. 
 
Figure 3.23. Cyanide (100 mM) binding to R26A CPO in phosphate buffer, pH 6.0. 
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Figure 3.24. Cyanide (100 mM) binding to N33A CPO in phosphate buffer, pH 6.0. 
 
Figure 3.25. Cyanide (100 mM) binding to R26A/N33A CPO in phosphate buffer, pH 6.0. 
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        Since the pre-requisite for using Eq. 3.1 to determine Kd is titrations with excess 
ligand, 1-10 mM (for mutants) or 2-10 mM (for WT) cyanide was added to protein 
solutions (3-8 μM) in titration studies. Upon addition of 2 mM CN- to the WT CPO (red 
spectrum), the Soret band shifted from 398 nm to 439 nm (Fig. 3.26, A). Upon gradual 
increase of CN- concentration, the Soret peak has remained at 439 nm while absorption has 
slightly increased. The shapes of other WT-CN spectra (4-10 mM CN-) are essentially 
identical, and there is no isosbestic point formed by these spectra indicating the presence 
of a single species in the solution at higher ligand concentrations. The spectrum of WT 
CPO after addition of 2 mM CN- (red) has a slightly different shape, and it possesses an 
isosbestic point (~427 nm) with spectra taken at higher CN- concentrations. This isosbestic 
point can be explained by the presence of the equilibrium between uncomplexed WT and 
WT-CN upon initial addition of CN-. Once the concentration of the ligand is increased, the 
equilibrium shifts to WT-CN side, and no further changes in the WT-CN spectra are 
observed. Since the shift of the Soret band is observed upon addition of 2 mM CN-, WT 
has been titrated with 10-800 μM cyanide to observe gradual changes in the WT spectrum. 
However, at these cyanide concentrations the protein to ligand ratio is smaller with the 
highest being approximately 1:100, which introduces larger error when using Eq. 3.1 for 
Kd determination. 
        Upon addition of lower concentrations of CN- (10-800 μM) to the WT CPO, the 
intensity of the Soret band at 398 nm has gradually decreased while a new peak has formed 
at 439 nm, indicating formation of WT-CN complex (Fig. 3.26, B). The isosbestic point at 
427 nm is consistent with the presence of two species in the solution, uncomplexed WT 
CPO and WT bound to cyanide. The Kd value calculated in this study, 130.0±6.5 μM, is 
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close to the Kd reported previously for CPO-CN at pH 6.0, 95±10 µM (243). The difference 
in values may arise from temperature variations during titrations and the fact that the 
protein to ligand ratio was not high enough as required for calculations using Eq. 3.1. 
However, addition of higher concentrations of the cyanide did not produce large enough 
change in the spectrum of the WT that is needed for Kd determination. Thus, Kd result 
here should be treated as an estimate. 
        When 1 mM CN- is added to the mutants, the intensity of the Soret peak decreases 
and it red-shifts to 421 nm for R26A and N33A mutants (Figs. 3.27 and 3.28) and to 422 
nm for R26A/N33A (Fig. 3.29). However, when CN- concentration is increased, the Soret 
band moves to 422 nm, 425 nm, and 430 nm for R26A, N33A, and R26A/N33A, 
respectively, while band intensities decrease further. The presence of the isosbestic point 
in all mutant spectra is consistent with the equilibrium between uncomplexed CPO and 
CPO-CN species. Higher CN- concentrations (mM range) required to observe spectral 
changes indicate that cyanide has lower affinity for the mutants.  The data for Kd 
determination is plotted in Fig. 3.30. Calculated Kd values for R26A, N33A, and 
R26A/N33A are 3.6 mM, 10.5±1.0 mM, and 3.8±0.4 mM, respectively, which confirms 
that CN- has lower affinity for the mutants. The Kd result for R26A mutant does not include 
the standard deviation and should be treated with caution since only one trial was 
performed because of the low yield of this mutant. 
        Previous studies on ligand binding to CPO revealed that cyanide diffuses into the 
distal heme pocket in a protonated form, HCN, and loses its proton upon binding to the 
heme iron (174, 220). Since WT CPO has no distal ligand, HCN can bind to the heme more 
readily. In contrast, R26A, N33A, and R26A/N33A CPO have low-spin ferric heme and 
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likely possess water or another amino acid as a distal ligand that competes with CN- for 
binding to the heme, which would explain lower CN- affinity for the mutants. 
 
Figure 3.26. Titration of WT CPO with cyanide in phosphate buffer, pH 6.0. A. 2-10 
mM CN-. B. 10-800 µM CN-. 
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Figure 3.27. Titration of R26A CPO with CN- (1-10 mM) in phosphate buffer, pH 6.0. 
 
 
Figure 3.28. Titration of N33A CPO with CN- (1-10 mM) in phosphate buffer, pH 6.0. 
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Figure 3.29. Titration of R26A/N33A with CN- (1-10 mM) in phosphate buffer, pH 6.0. 
 
Figure 3.30. CN- Kd determination for the mutant CPO (Only 1 trial for R26A was 
performed because of the limited amount of the protein, hence there are no error bars). 
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        The Hill plot (Fig. 3.31) (240) was used to explore the binding stoichiometry of CN- 
to mutant CPOs. The slopes of all three graphs are very close to 1 confirming that 
CN- binding to the R26A, N33A, and R26A/N33A mutants follows the same stoichiometry 
as in binding to the WT: one molecule of cyanide binds to one molecule of CPO.  
 
Figure 3.31. The Hill plot (determination of mutant CPO-CN binding stoichiometry). The 
slopes of R26A, N33A, and R26A-N33A plots are 1.0048, 0.9943, and 1.0249, 
respectively.  
 
        Cyanide (100 mM) binding was also performed at pH 12.0 to probe its ability to bind 
to mutant CPO in deprotonated form (pKa 9.14). The WT spectrum at pH 12.0 is consistent 
with the second alkaline transition occurring near pH 11.0, reported previously for CPO 
(Fig. 3.32) (220). Alkaline transitions at pH 12.0 have been also observed in N33A and 
R26A/N33A CPOs (Fig. 3.33 and 3.34). The CN- binding to R26A at alkaline pH has not 
been performed because of the low yield of R26A. Spectral properties of CPO and cyanide 
complexes are summarized in Table 3.4.  
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Figure 3.32. Cyanide (100 mM) binding to WT CPO in phosphate buffer, pH 12.0. 
 
Figure 3.33. Cyanide (100 mM) binding to N33A CPO in phosphate buffer, pH 12.0. 
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Figure 3.34. Cyanide (100 mM) binding to R26A/N33A in phosphate buffer, pH 12.0. 
        When 100 mM CN- is added to the WT, N33A, and R26A/N33A, the spectra of all 
three complexes look essentially the same, with the Soret band at 422 nm, and do not 
change after 1-hour incubation suggesting that these cyanide derivatives are different from 
those formed at pH 6.0. This result is expected since the native forms of the WT and 
mutants at pH 12.0 are different from those at pH 6.0.  
        The mechanism of CN- binding at alkaline pH is more difficult to interpret since 
several changes are occurring. First, HCN ionizes to CN- possibly making it more difficult 
to diffuse into the active site and/or bind to the heme iron. Second, WT CPO undergoes an 
alkaline transition that seems to differ from that in the mutants judging from the spectra at 
pH 12.0. My results for CN- binding at alkaline pH are consistent with decreased 
CN- affinity to the WT (Kd of 4 mM) reported at pH 9.5 (174). However, it should be noted 
that the cyanide derivative of the WT CPO at pH 9.5 is different from that at pH 12.0 since 
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its Soret peak is 15 nm red-shifted from that in the WT-CN complex at pH 12.0 (437 nm 
vs. 422 nm), and the second alkaline transition in WT CPO takes place at pH 11, thus CN- 
binds to two different forms of CPO.  
Table 3.4. UV-Vis spectral properties of ferric WT and mutant CPO and their cyanide 
complexes at pH 6.0 and pH 12.0. (s), (n.s), and (s.s) denote the presence of a shoulder, no 
shoulder, or a slight shoulder, respectively. 
Protein δ band 
(nm) 
Soret 
 (nm) 
β band 
(nm) 
α band 
(nm) 
CT 
(nm) 
WT CPO (pH 6) -- 398 515 550 650 
WT-CN (pH 6) 364 439 -- 564 -- 
WT CPO (pH 12) 361 422 -- 547 -- 
WT-CN (pH 12) 361 422 -- 547 -- 
R26A (pH 6) 354 418  
(s) 
540 568 644 
R26A-CN (pH 6) 364 436→432 -- 560 -- 
N33A (pH 6) 356 420 
 (n.s) 
540 575 -- 
N33A-CN (pH 6) 364 437→427 -- 557 -- 
N33A (pH 12) 363 (as a 
shoulder) 
385 -- -- -- 
N33A-CN (pH 12) 363 422 -- 547 -- 
R26A/N33A (pH 6) 356 421  
(s.s) 
540 575 644 
(low) 
R26A/N33A-CN (pH 6) 364 439→437 -- 555 -- 
R26A/N33A (pH 12) 360 422 543 578 646 
R26A/N33A-CN (pH 
12) 
360 436→430 -- 555 -- 
 
        Interestingly, the spectrum of the WT after transition at pH 7.5 to the low-pin form is 
similar to the spectra of the mutants at pH 6.0 that also possess a low-spin heme iron, and 
the cyanide Kd values for these CPO forms are comparable (4 mM for the WT vs. 3.6 mM, 
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3.8 mM, and 10.5 mM for the mutants). However, the WT and mutant low-spin forms must 
be different since the low-spin WT is enzymatically inactive, while the mutants are active. 
3.4 Conclusion 
        H-bonding networks within the active sites are conserved features in many heme 
proteins. Such networks in the distal and proximal heme sides of peroxidases and 
cytochrome P450s are important for their structure and catalysis. My study examined the 
contributions of the H-bonding network formed by Arg 26-Asn 37 and Ala 27-Asn33 on 
the proximal side of CPO to the structural and thus spectroscopic properties of the enzyme. 
The R26A, N33A, and R26A/N33A CPO were characterized with various spectroscopic 
techniques and compared to the WT. 
        My results have shown that removal of H-bonds in either of the residue pairs does not 
significantly affect secondary structure. However, alpha-helical content is dramatically 
increased if all H-bonds are removed. Additionally, all mutants exhibit differences in 
tertiary CD, which indicates that the proximal H-bond network is important for maintaining 
the tertiary structure of CPO, which in turn influences the environment of the active site. 
Carbon monoxide and cyanide binding results have demonstrated that removal of H-bonds 
in the proximal site of CPO induces structural changes that have a larger effect on binding 
of anionic ligand than on binding of a neutral ligand.  
        It is likely that removal of the proximal H-bonds changes the flexibility of helix A, 
affecting its position relative to the heme and influencing its interactions with the protein 
matrix. The dislocation of the helix A is likely to change the bond length between the iron 
and the proximal thiolate, which in turn would affect the heme environment and thus the 
catalytic properties of CPO discussed in the next chapter. 
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CHAPTER IV. 
EFFECTS OF HYDROGEN BOND NETWORK IN THE PROXIMAL HELIX ON 
CATALYTIC PROPERTIES OF CHLOROPEROXIDASE 
4.1 Background 
        As mentioned in Chapter I, CPO is a heme-thiolate protein that belongs to the 
peroxidase-peroxygenase family of enzymes (28, 71). Many heme enzymes are capable of 
efficiently catalyzing one or two particular types of reactions, depending on the class of the 
enzyme. However, CPO is capable of catalyzing a plethora of reactions such as 
halogenation, peroxidation, peroxide dismutation, and epoxidation that are characteristic 
of multiple enzyme classes (112, 113, 141, 142). The aforementioned reactions and other 
oxidations are catalyzed by the reactive form of CPO, Cpd I, which is formed by binding 
of hydrogen peroxide to the ferric resting state of the protein. The proximal oxygen of the 
peroxide is deprotonated by Glu 183, producing the so called Compound 0 (Cpd 0), 
followed by an initial homolytic O-O bond scission. The homolytic process becomes 
heterolytic as the proton which was removed from the proximal oxygen, is transferred to 
the distal oxygen, and a water moiety departs, producing the oxo-ferryl cationic-radical 
intermediate, Cpd I (106, 226).  
        The formation rates and reactivity of Cpd I depend on the pKa of the distal ligand and 
electron-donating ability of the proximal ligand (204, 244). The higher basicity of the distal 
ligand (H2O2) would result in slower formation of Cpd 0 since proton removal from 
peroxide-bound ferric heme would be more difficult. However, if the pKa is too low it 
would result in slower formation of Cpd I from Cpd 0 because of the difficulty in 
protonating Cpd 0. Additionally, the electronegativity of the proximal thiolate creates a so-
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called ‘push effect’ that directly influences distal ligand pKa and Cpd I redox potential 
(234, 244-246). The ‘push’ provided by the proximal thiolate increases the basicity of the 
distal oxygen in Cpd 0, thus facilitating water release and Cpd I formation. However, the 
‘push’ concurrently decreases the redox potential and thus the reactivity of Cpd I. To 
modulate the ‘push’ for the optimal activity without preventing formation of Cpd 0,  CPO 
and other heme thiolate enzymes evolved mechanisms for reducing thiolate 
electronegativity via Cys-amide H-bonds and the electropositive environment of the N-
terminus of the proximal helix (244). 
        Hydrogen bonding between a proximal Cys and polypeptide amides is a common 
feature of many heme thiolate proteins including CPO, P450s, and NO synthase (71, 98, 
247). In CPO, Cys 29 is H-bonded to the peptide NH groups of Ala 31 and Leu 32 situated 
at the N-terminus of helix A, while in P450cam the proximal Cys 357 is H-bonded to NH 
groups of Leu 358, Gly 359, and Gln 360 (71, 98).  These H-bonds contribute to the 
increase of the iron redox potential by decreasing the negative charge on the Cys ligand, 
and stabilize the thiolate by preventing its protonation and protecting against diatomic 
reactants, all of which result in the formation of inactive forms of the enzyme (101, 102). 
As demonstrated by mutation studies on P450cam by Yoshioka et al., removal of thiolate-
amide bonds in L358P, Q360P, and Q360L mutants results in increased push effect and 
reduced redox potential of the enzyme (101, 211). 
        Once Cpd I is formed in CPO, it is able to follow different catalytic pathways. For 
example, Cpd I can either form oxo-ferryl (possibly, hydroxy-ferryl) Cpd II in the 
peroxidation pathway, oxo-ferric Cpd X in halogenation pathway, or return to its resting 
state via dismutation and P450 pathways (104, 107, 109). One-electron oxidations that 
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occur via the peroxidation pathway include peroxidation and oxidative de-halogenation 
reactions and have been proposed to occur on the surface of the enzyme (112, 127, 137, 
138). Although Cpd II, an intermediate formed during one-electron oxidations, is 
postulated to be an oxo-ferryl species, its protonation state is still debated. Computational 
studies (107, 108) have suggested the iron(IV)-hydroxide species to be the major form of 
Cpd II; however, this hypothesis has not been confirmed experimentally. Two-electron 
oxidations include a variety of reactions such as halogenation, epoxidation, sulfoxidation, 
peroxide dismutation, and are suggested to occur at the active site of CPO, except for 
halogenations (112, 113, 141, 142). Compound X, ferric Fe-HOCl, is formed during 
chlorination reactions catalyzed by CPO (109). No intermediates besides Cpd I have been 
identified in other two-electron oxidations. The ability of CPO to catalyze such diverse 
reactions is postulated to be a result of its unique active site structure.  
        Chloroperoxidase is folded into N- and C-terminal domains with the heme group 
located between the domains. The active site of CPO is a peroxidase-P450 hybrid with a 
peroxidase-like polar distal environment and a P450-like proximal thiolate ligation (71). 
The proximal heme ligand, Cys 29, is located in the N-terminus of helix A, which is almost 
perpendicular to the heme plane (71). Interestingly, in cytochromes P450 and most other 
peroxidases with the imidazolate ligation, the helix containing the proximal ligand is 
situated in the C-terminal domain and is parallel to heme (98). The electropositive helix 
environment reduces the electronegativity of the proximal Cys, thus contributing to the 
increase in redox potential, and has been termed the ‘proximal helix effect’. The almost 
perpendicular orientation of the proximal helix to the heme in CPO provides a larger 
increase in redox potential than observed in P450 with its parallel helix (99, 100, 248). 
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Thus, Cys-amide H-bonds together with the proximal helix dipole have a significant 
influence on the reactivity of CPO.  
        Hydrogen bond networks are important structural features in heme imidazolate 
enzymes as well. In many peroxidases, the distal His-Arg pair is essential for efficient 
production of Cpd I (64-66). In CPO, the role of the His-Arg pair is carried out by Glu 183 
H-bonded to His 105. Both Arg in peroxidases and His in CPO provide a particular 
orientation to the catalytic His and Glu, respectively, and aid in achieving optimal rates of 
Cpd I formation (202, 249, 250). Proximal H-bond networks consisting of His-Asp-
Trp/Phe and His-Asn-Arg are conserved in peroxidases-catalases and peroxidases-
cyclooxygenases, respectively. These networks are believed to stabilize higher oxidation 
states of Cpd I and Cpd II by de-protonating the proximal His at Nδ position and 
maintaining shorter Fe-imidazolate bond distances in peroxidases as compared to globins 
that lack such a network (251, 252).  
        There are several amino acids in the proximal helix of CPO that also form a H-bonding 
network, in particular Arg 26-Asn 37 and Ala 27-Asn 33. It is reasonable to suggest that 
this H-bond network provides structural support for the proximal helix and helps its 
positioning in a particular orientation relative to the heme, possibly influencing the 
catalytic properties of the enzyme. However, no research has been done on the role of this 
proximal H-bond network in defining the biochemical properties of CPO. 
        In this study, I investigated how deletion of H-bonds between Arg 26-Asn 37 and Ala 
27-Asn 33 affect catalytic properties of CPO. I replaced Arg 26 and Asn 33 with Ala to 
disrupt H-bonding and characterized R26A, N33A, and R26A/N33A CPO using various 
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enzymatic assays and UV-Vis spectrophotometry. My results show that the H-bonding 
network of the proximal helix is important for maintaining the catalytic diversity of CPO. 
4.2 Experimental procedures 
        All the chemicals and materials used are described in section 2.2.1. 
4.2.1 Construction of R26A, N33A, and R26A/N33A CPO mutants  
        To investigate the role of the hydrogen bond network in the proximal helix of CPO 
(Arg 26-Asn 37 and Ala 27-Asn 33) in catalysis, R26A, N33A, R26A/N33A mutants were 
constructed. Gene construction, expression, and purification of the mutants were 
performed as described in sections 3.2.1 and 3.2.2.  
4.2.3 Enzymatic assays 
        To investigate catalytic properties of the mutants lacking hydrogen bonds in the 
proximal helix, enzymatic assays described in section 2.2.7 were performed with the 
following modifications. Enzyme amounts used for the ABTS assay at various pH are listed 
in Table 4.1. 
Table 4.1. Enzyme amounts used in ABTS assay at different pH. 
pH WT (µM) Mutant (µM) 
2.75, 3.0 0.03 0.03 
3.5 0.1 0.03 
4.0, 4.5 0.5 0.03 
5.0, 5.5 2.0 0.1 
6.0 5.0 0.2 
 
        Styrene epoxidation assay (15) was performed in 100 mM phosphate-citrate or 
phosphate buffer (pH 2.75, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 7.0, 8.0). Protein concentration 
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was 0.3 µM. MCD assay was performed in 100 mM phosphate-citrate or phosphate buffer 
(pH 2.75, 3.0, 3.5, 4.0, 4.5, 5.0). Protein concentration was 0.6 µM. Finally, dismutation 
assay was performed in 100 mM phosphate-citrate or phosphate buffer (pH 2.4, 3.0, 3.5, 
4.0, 4.5, 5.0, 5.5, 6.0). Protein concentration was 0.5 µM. 
4.3 Results and discussion 
        In general, catalytic properties of heme proteins are influenced by the heme iron redox 
potential, architecture of the active site, and electrostatic interactions present in the distal 
and proximal sides (48, 106, 207, 244). To examine the effect of the proximal hydrogen 
bonding on catalytic properties of CPO, chlorination (MCD), dismutation (H2O2), 
peroxidation (ABTS), and epoxidation (styrene) assays were performed.  
4.3.1 Chlorination and dismutation activities of WT and mutant CPO at various pH 
        The chlorination reaction catalyzed by WT CPO is most efficient at very acidic pH 
with highest rates at pH 2.75.  Chlorination proceeds via one two-electron step with the 
formation of Cpd I and Cpd X (109, 141). Thus, the rate of chloride oxidation depends on 
the formation rates of the two intermediates. Since the rate of Cpd I formation has been 
shown to be independent of pH (104, 106), Cpd X must be responsible for differences in 
activities observed at various pH.  Indeed, it has been demonstrated that only protonated 
Cpd X is able to chlorinate MCD (109), which explains WT’s high chlorination activity at 
acidic pH. In contrast, the mutant CPOs (R26A, N33A, and R26A/N33A) lacking H-bonds 
in the heme proximal helix almost completely abolish chlorination activity at all pH values 
checked (2.4-5.0, Figs. 4.1-4.2). The loss of chlorination activity may be explained by the 
decrease in the Cpd I redox potential that is affected by the ‘push’, spin state, and the extent 
of heme burial.  
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Figure 4.1. pH profiles of WT and mutant CPO chlorination activities (some error bars are 
smaller than the point size and are not visible on the graph). 
 
Figure 4.2. pH profiles of R26A, N33A, and R26A/N33A CPO chlorination activities 
(some error bars are smaller than the point size and are not visible on the graph). 
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Figure 4.3. pH profiles of WT, R26A, N33A, and R26A/N33A CPO dismutation activities 
(some error bars are smaller than the point size and are not visible on the graph). 
Since disruption of the H-bond network in the heme proximal helix affects tertiary 
structures of the mutants, it is likely that perturbations in the active site cause increase in 
the electron push from the thiolate ligand, which in turn decreases redox potential. For 
example, removal of the H-bonds may affect the positioning of the proximal helix, whose 
dipole contributes to the thiolate ‘push’ decrease. Changes in helix A orientation may result 
in a smaller electron density withdrawal from the heme that would reduce the redox 
potential. 
        In P450s with a parallel position of the proximal helix relative to the heme, the helix 
dipole results in only a 70 mV redox potential increase of Fe(III)/Fe(II) couple as opposed 
to 130 mV in CPO whose proximal helix is perpendicular to the heme (204). In addition, 
since the proximal helix of CPO contains Cys 29 ligated to the heme, changes in the 
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position of the helix may affect the orientation of the proximal thiolate, which in turn can 
affect the heme environment.  
        Tertiary structural changes, observed by CD, could have affected the heme exposure 
to the solvent, which would also contribute to the decrease of both the redox potential and 
catalatic activity of the enzyme (253, 254). This is consistent with negligible dismutation 
activity of the mutants (Fig. 4.3). 
        Hydrogen peroxide decomposition, a two-electron oxidation reaction, is catalyzed by 
WT CPO most efficiently at acidic pH with the highest rates at pH 4.5-5.0. N33A and 
R26A/N33A do not have any dismutation activity in the acidic pH range, while R26A 
mutant has a very low activity at pH 4.5-5.0. The low catalatic activity of R26A indicates 
that it might have a slightly higher redox potential than the other two mutants, which would 
allow peroxide dismutation though not be high enough for chloride oxidation. 
4.3.2 Peroxidation and epoxidation activities of WT and mutant CPO at various pH 
        The optimal pH range for ABTS peroxidation by the WT CPO is 2.75-3.0. The activity 
of WT CPO is decreased more than 10-folds at pH 3.5, and peroxidation is negligible at 
pH above 4.0. In contrast, R26A and N33A possess significantly higher peroxidation 
ability in pH range 3.5-5.0 with the optimal activity at pH 3.5 while R26A/N33A is more 
active at all pH checked (Fig. 4.4). The peroxidation activity of the double mutant is about 
2-fold higher than that of R26A and N33A at pH 3.5. 
        The shift in optimal pH for peroxidation activity can be explained by the possible 
increase in the pKa of Cpd II. High activity of the WT below pH 3.5 suggests that 
protonation of Cpd II might be required for the peroxidation reaction to occur, similarly to 
the protonation of Cpd X in the halogenation pathway, and that Cpd II has a low pKa 
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(below 3.5).  In mutant CPOs, the pKa of Cpd II might be higher, and that would result in 
the formation of the active protonated Cpd II at higher pH. Hence, peroxidation is able to 
occur over a wider pH range. This observation is also consistent with the proposed inverse 
relation of the heme redox potential and pKa of the distal ligand. The lower redox potential 
of mutant CPOs that can be inferred from their inability to oxidize chloride would increase 
the pKa of the distal ligand. 
 
 
Figure 4.4. pH profiles of WT and mutant CPO peroxidation activities (some error bars 
are smaller than the point size and are not visible on the graph). 
        Epoxidation of styrene, catalyzed by mutant CPOs, occurs at significantly higher rates 
as compared to the WT. Wild-type CPO oxidizes styrene over a wide pH range, 2.75-7.0 
(Fig. 4.5). A significant decrease in activity is observed at pH higher than 7.0 because of 
the formation of the inactive alkaline species of CPO. The rates of styrene epoxidation do 
not seem to heavily depend on pH since the difference between specific activities, for 
example, at pH 6.0 and 2.4 is only 2-fold. A similar situation is observed in epoxidations 
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catalyzed by the mutants, which are active in the pH range 2.4-9.0 with specific activities 
varying only about 1.5-fold (Fig. 4.5). This observation indicates that epoxidation does not 
require a catalytic intermediate, whose protonation state determines the reaction rates, as 
has been observed in chlorination and peroxidation assays. Also, it should be noted that in 
the case of mutant CPOs, the enzymes remain very active at pH 9.0, suggesting that mutant 
CPOs do not form the inactive alkaline form similarly to WT CPO. This result is also 
confirmed by electronic absorption spectra of the mutants showing that native enzyme 
forms start changing only at pH 10.0. 
 
Figure 4.5. pH profiles of WT and R26A CPO epoxidation activity (some error bars are 
smaller than the point size and are not visible on the graph). 
        In mutant CPOs, the lack of catalatic activity, which competes with other reactions 
for Cpd I, is expected to contribute to the increase in peroxidation and epoxidation rates. 
During hydrogen peroxide decomposition, a molecule of hydrogen peroxide binds the 
ferric enzyme, and Cpd I is formed. Next, another molecule of hydrogen peroxide binds to 
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Cpd I. Hydrogen peroxide is decomposed into water and oxygen while Cpd I is converted 
back to the ferric resting state. This process results in premature depletion of the oxidizing 
agent necessary for the formation of Cpd I, which is required for peroxidation and 
epoxidation. When dismutation is absent, more Cpd I is available in the reaction and 
hydrogen peroxide is not depleted via the dismutation pathway.  
        As judged from tertiary CD (chapter 3), another possible contribution to the increase 
in epoxidation activity of the mutants is the changes in accessibility of the active site by 
substrates, which is important for two-electron oxidations by heme enzymes (237). Large 
changes in the secondary structure of the double mutant, having the highest epoxidation 
rates, are consistent with this hypothesis. 
4.3.3 Comparison of WT and mutant CPO activities at optimal pH 
        pH 2.75 and pH 4.5 were chosen to compare specific activities of WT and the mutants 
since these are the optimal pH values for chlorination/peroxidation and 
epoxidation/dismutation activities, respectively. Furthermore, the majority of specific 
activities of the WT and other mutant CPOs reported in the literature were measured at pH 
2.75 (chlorination) and pH 4.5 (dismutation, peroxidation, epoxidation). Hence, my results 
for mutant activities can be compared to the activities of other CPO mutants. 
        At pH 2.75, R26A and N33A possess about 60% peroxidation activity of that of the 
WT (Fig. 4.6). However, at pH 4.5, R26A and N33A showed around 80-fold and 70-fold 
increase in peroxidation activity, respectively (Fig. 4.7). The double mutant, R26A/N33A, 
is more active than the WT at both pH 2.75 and 4.5, showing 1.3-fold and an astounding 
250-fold increase in peroxidation, respectively (Figs. 4.6-4.7). All mutants are more active 
in epoxidation assay as well, showing 3.5-fold, 2.8-fold, and 7.2-fold increase (R26A, 
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N33A, and R26A/N33A, respectively) (Fig. 4.8). Different trends are observed in 
chlorination and dismutation assays. 
 
 
Figure 4.6. Relative peroxidation activities of the WT and mutant CPOs at pH 2.75. 
 
 
Figure 4.7. Relative peroxidation activities of the WT and mutant CPOs at pH 4.5. 
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Figure 4.8. Relative epoxidation activities of the WT and mutant CPOs at pH 4.5. 
 
 
Figure 4.9. Relative dismutation activities of the WT and mutant CPOs at pH 4.5. 
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Figure 4.10. Relative chlorination activities of the WT and mutant CPOs at pH 2.75. 
        R26A shows a slight dismutation activity (5% of that of the WT) (Fig. 4.9). All 
mutants possess negligible chlorination activity (Fig. 4.10).  These results suggest that the 
redox potentials of R26A, N33A, and R26A/N33A mutants might be lower than that of the 
WT.  
        Overall, my results indicate that H-bond network in the proximal helix A of CPO 
plays an important role in maintaining the secondary and tertiary structures of CPO and 
contributes to its high chlorination and dismutation activities. However, the presence of 
these H-bonds also results in decreased epoxidation and peroxidation rates, especially at 
slightly acidic and neutral pH. 
4.4 Conclusion 
        There has been quite a substantial amount of work published on heme protein catalysis 
over the years. It is clear that heme proteins evolved multiple mechanisms that work 
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together to carry out their particular biological functions. Many factors that influence 
catalytic properties of heme enzymes have been identified including types of electronic 
structures, nature of heme ligands, electrostatic interactions, and H-bond networks. 
However, the importance and particular contributions of many structural features in 
catalysis remain to be delineated. No research has been published on the role of the H-bond 
network in the proximal helix of CPO on its catalysis. In this work, I employed rational 
design to investigate the role of this H-bond network in the catalytic properties of CPO. 
Three CPO mutants (R26A, N33A, and R26A/N33A) were engineered and characterized 
using various enzymatic assays. My results have shown that the proximal H-bond network 
is as important for the catalytic diversity of CPO as the proximal thiolate ligand, and is also 
responsible for providing CPO with its high chlorination and dismutation activities. My 
research contributes to the ongoing exploration of factors that influence heme catalysis and 
helps us better understand the structure-function relations in heme-thiolate proteins in 
general and in CPO in particular. 
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CHAPTER V. 
PERSPECTIVES 
        The results of this work show that several structural features of the proximal heme 
pocket, particularly the axial thiolate and H-bond network, strongly influence the ligand-
binding and catalytic properties of CPO. Although C29, R26, and N33 in the proximal site 
do not directly participate in catalysis, they influence the structure of the protein and the 
heme environment, which in turn significantly affect the catalytic behavior of CPO. 
        The CPO mutants investigated in this work (C29H, R26A, N33A, and R26A/N33A) 
can be further studied by RR and NMR spectroscopies to obtain more information about 
the structure of the active site. Solving crystal structures of the mutants would help better 
understand ligand-binding and catalysis results. The ligand-binding properties of mutant 
CPO can be further investigated with thiocyanate, nitric oxide, halides, etc. to gain insights 
into factors affecting ligand binding. Catalytic behavior can be further explored with other 
reactions such as sulfoxidation, hydroxylation, bromination together with various 
substrates. The enantioselectivity of oxygen insertions would present an attractive target 
for the pharmaceutical and chemical industries. Investigations of CPO with other point 
mutations in the active site or disulfide bond region would be also interesting. 
        Mutant CPO production requires large amounts of media because of much lower 
protein yields as compared to the WT. Hence, determination of factors influencing the 
expression of CPO mutants and their secretion in the holo form, and optimization of fungal 
expression systems would help increase mutant CPO yields, encouraging further research 
on CPO and other heme proteins, especially those ones that are understudied because of 
the difficulties associated with obtaining good yields.    
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APPENDIX 
Figure A1. Primers used for construction of C29H/C79H and C29H/C79H/C87H CPO 
(His mutation is shown in bold). 
 
Coding strain - C29H/C79H primer 1 (C29H pCPO was used as a template) 
5’- GTCGTCCACGAGTACGTTACTGGCTCCGACTGTGGTGACAGC - 3’ 
Non-coding strain – C29H/C79H primer 2 
5’- AGCCAGTAACGTACTCGTGGACGACGAAGGTGTTGTCAGAGC - 3’ 
 
Coding strain - C29H/C79H/C87H primer 1 (C29H/C79H pCPO was used as a template) 
5’- CTCCGACCATGGTGACAGCCTTGTCAACCTGACTC - 3’ 
Non-coding strain – C29H/C79H/C87H primer 2 
5’- GTCACCATGGTCGGAGCCAGTAACGTACTCGTG - 3’ 
 
Figure A2. Nucleotide sequence of full-length WT CPO gene. 
 
ATGTTCTCCAAGGTCCTTCCCTTCGTGGGAGCGGTTGCCGCCCTCCCTCACTC
CGTCCGTCAGGAGCCTGGCTCCGGCATTGGCTACCCATACGACAACAACACC
CTGCCATATGTCGCCCCAGGTCCTACCGACTCTCGTGCTCCTTGCCCAGCTCT
GAACGCTCTTGCCAACCACGGTTACATTCCTCACGATGGCCGTGCCATCAGC
AGGGAGACCCTCCAGAACGCTTTCCTCAACCACATGGGTATTGCCAACTCCG
TCATTGAGCTTGCTCTGACCAACGCCTTCGTCGTCTGCGAGTACGTTACTGGC
TCCGACTGTGGTGACAGCCTTGTCAACCTGACTCTGCTCGCCGAGCCCCACGC
TTTCGAGCACGACCACTCCTTCTCCCGCAAGGATTACAAGCAGGGTGTCGCC
AACTCCAACGACTTCATCGACAACAGGAACTTCGATGCCGAGACCTTCCAGA
CCTCTCTGGATGTCGTTGCAGGCAAGACCCACTTCGACTATGCCGACATGAA
CGAGATCCGCCTTCAGCGCGAGTCCCTCTCCAACGAGCTTGACTTCCCCGGTT
GGTTCACCGAGTCCAAGCCAATCCAGAACGTCGAGTCTGGCTTCATCTTCGCC
CTTGTCTCTGACTTCAACCTGCCCGACAACGATGAGAACCCTCTGGTTCGCAT
TGACTGGTGGAAGTACTGGTTCACCAACGAGTCCTTCCCATACCACCTCGGCT
150 
 
GGCACCCCCCGTCTCCAGCCAGGGAGATCGAGTTCGTCACCTCCGCCTCCTCC
GCTGTCCTGGCTGCCTCTGTCACCTCTACTCCATCTTCCCTTCCATCCGGTGCC
ATCGGCCCAGGTGCCGAGGCTGTCCCTCTCTCCTTCGCCTCCACCATGACCCC
ATTCCTCCTCGCCACCAATGCTCCTTACTACGCCCAGGACCCAACTCTCGGCC
CCAACGACAAGCGTGAGGCTGCCCCAGCTGCCACCACCTCCATGGCCGTCTT
CAAGAACCCATACCTCGAGGCCATTGGCACCCAGGACATCAAGAACCAGCA
GGCTTACGTCAGCTCCAAGGCTGCTGCCATGGCCTCTGCCATGGCCGCCAAC
AAGGCCCGCAACCTTTAA 
 
Figure A3. Amino acid sequence of WT CPO including signal peptide (1-20) and 
propeptide (322-373). 
 
1     MFSKVLPFVG AVAALPHSVR QEPGSGIGYP YDNNTLPYVA PGPTDSRAPC 
51   PALNALANHG YIPHDGRAIS   RETLQNAFLN HMGIANSVIE  LALTNAFVVC 
101 EYVTGSDCGD SLVNLTLLAE PHAFEHDHSF SRKDYKQGVA NSNDFIDNRN 
151 FDAETFQTSL DVVAGKTHFD YADMNEIRLQ RESLSNELDF PGWFTESKPI 
201 QNVESGFIFA LVSDFNLPDN  DENPLVRIDW WKYWFTNESF PYHLGWHPPS  
251 PAREIEFVTS  ASSAVLAASV  TSTPSSLPSG  AIGPGAEAVP  LSFASTMTPF 301 
LLATNAPYYA QDPTLGPNDK REAAPAATTS MAVFKNPYLE AIGTQDIKNQ 
351 QAYVSSKAAA MASAMAANKA RNL 
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